author_name,title,journal_info,cited_by,year,number_of_authors,authors_list,Order in which the author we're interested in appears
Stefan D. Anker,Heart disease and stroke statistics—2012 update: a report from the American Heart Association,"Circulation 125 (1), e2-e220",33211,2012,38,"Writing Group Members, VL Roger, AS Go, DM Lloyd-Jones, EJ Benjamin, ...",
Stefan D. Anker,2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart …,"European heart journal 42 (36), 3599-3726",9701,2021,31,"TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ...",
Stefan D. Anker,2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure,"Kardiologia Polska (Polish Heart Journal) 74 (10), 1037-1147",24593,2016,21,"P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,The Seattle Heart Failure Model: prediction of survival in heart failure,"Circulation 113 (11), 1424-1433",2380,2006,14,"WC Levy, D Mozaffarian, DT Linker, SC Sutradhar, SD Anker, AB Cropp, ...", Stefan D Anker
Stefan D. Anker,Ferric carboxymaltose in patients with heart failure and iron deficiency,"New England Journal of Medicine 361 (25), 2436-2448",2425,2009,16,"SD Anker, J Comin Colet, G Filippatos, R Willenheimer, K Dickstein, ...",Stefan D Anker
Stefan D. Anker,ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 …,"European heart journal 33 (14), 1787-1847",11568,2012,72,"Authors/Task Force Members, JJV McMurray, S Adamopoulos, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular …","European heart journal 34 (39), 3035-3087",2413,2013,85,"Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ...", Stefan D Anker
Stefan D. Anker,"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and …","European heart journal 41 (2), 255-323",4434,2020,24,"F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ...",
Stefan D. Anker,Antiinflammatory therapy with canakinumab for atherosclerotic disease,"New England journal of medicine 377 (12), 1119-1131",7804,2017,28,"PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...", Stefan D Anker
Stefan D. Anker,2013 ESH/ESC Guidelines for the management of arterial hypertension,"Arterial Hypertension 17 (2), 69-168",23516,2013,25,"G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ...",
Stefan D. Anker,2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management …,"European heart journal 35 (35), 2383-2431",2463,2014,123,"Authors/Task Force Members, SD Kristensen, J Knuuti, A Saraste, ...", Stefan Anker
Stefan D. Anker,Definition and classification of cancer cachexia: an international consensus,"The lancet oncology 12 (5), 489-495",5638,2011,19,"K Fearon, F Strasser, SD Anker, I Bosaeus, E Bruera, RL Fainsinger, ...", Stefan D Anker
Stefan D. Anker,Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron‐deficient heart failure patients: an individual patient data meta‐analysis,"European journal of heart failure 20 (1), 125-133",469,2018,13,"SD Anker, BA Kirwan, DJ van Veldhuisen, G Filippatos, J Comin‐Colet, ...",Stefan D Anker
Stefan D. Anker,Cachexia: a new definition,"Clinical nutrition 27 (6), 793-799",2875,2008,22,"WJ Evans, JE Morley, J Argilés, C Bales, V Baracos, D Guttridge, A Jatoi, ...", Stefan D Anker
Stefan D. Anker,Frailty consensus: a call to action,"Journal of the American Medical Directors Association 14 (6), 392-397",4248,2013,20,"JE Morley, B Vellas, GA Van Kan, SD Anker, JM Bauer, R Bernabei, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in heart failure with a preserved ejection fraction,"New England Journal of Medicine 385 (16), 1451-1461",2977,2021,41,"SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ...",Stefan D Anker
Stefan D. Anker,Cardiovascular and renal outcomes with empagliflozin in heart failure,"New England Journal of Medicine 383 (15), 1413-1424",3948,2020,39,"M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ...", Stefan D Anker
Stefan D. Anker,Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis,"European heart journal 43 (6), 474-484",465,2022,12,"R Agarwal, G Filippatos, B Pitt, SD Anker, P Rossing, A Joseph, P Kolkhof, ...", Stefan D Anker
Stefan D. Anker,Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure,"Circulation 139 (10), 1289-1299",471,2019,9,"BM Everett, JH Cornel, M Lainscak, SD Anker, A Abbate, T Thuren, ...", Stefan D Anker
Stefan D. Anker,Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure,"European heart journal 20 (9), 683-693",489,1999,11,"SD Anker, PP Ponikowski, AL Clark, F Leyva, M Rauchhaus, M Kemp, ...",SD Anker
Stefan D. Anker,Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology,"European journal of heart failure 9 (6-7), 684-694",473,2007,16,"M Metra, P Ponikowski, K Dickstein, JJV McMurray, A Gavazzi, CH Bergh, ...", Stefan Anker
Stefan D. Anker,Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology,"European journal of heart failure 13 (1), 1-10",501,2011,28,"T Eschenhagen, T Force, MS Ewer, GW De Keulenaer, TM Suter, ...", Stefan D Anker
Stefan D. Anker,Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives,"European heart journal 34 (11), 816-829",511,2013,5,"EA Jankowska, S von Haehling, SD Anker, IC Macdougall, P Ponikowski", Stefan D Anker
Stefan D. Anker,Cardiac cachexia: a syndrome with impaired survival and immune and neuroendocrine activation,"Chest 115 (3), 836-847",520,1999,2,"SD Anker, AJS Coats",Stefan D Anker
Stefan D. Anker,Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease,"Circulation 106 (1), 92-99",541,2002,9,"AP Bolger, R Sharma, W Li, M Leenarts, PR Kalra, M Kemp, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,Elevated soluble CD14 receptors and altered cytokines in chronic heart failure,"The American journal of cardiology 79 (10), 1426-1430",555,1997,6,"SD Anker, KR Egerer, HD Volk, WJ Kox, PA Poole-Wilson, AJS Coats",Stefan D Anker
Stefan D. Anker,Sarcopenia: a time for action. An SCWD position paper,"Journal of cachexia, sarcopenia and muscle 10 (5), 956-961",561,2019,22,"J Bauer, JE Morley, AMWJ Schols, L Ferrucci, AJ Cruz‐Jentoft, E Dent, ...", Stefan D Anker
Stefan D. Anker,Skeletal muscle function and its relation to exercise tolerance in chronic heart failure,"Journal of the American College of Cardiology 30 (7), 1758-1764",491,1997,7,"D Harrington, SD Anker, TP Chua, KM Webb-Peploe, PP Ponikowski, ...", Stefan D Anker
Stefan D. Anker,Uric acid in chronic heart failure: a marker of chronic inflammation,"European heart journal 19 (12), 1814-1822",511,1998,8,"F Leyva, SD Anker, IF Godsland, M Teixeira, PG Hellewell, WJ Kox, ...", SD Anker
Stefan D. Anker,Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and …,"Circulation 103 (7), 967-972",505,2001,11,"P Ponikowski, DP Francis, MF Piepoli, LC Davies, TP Chua, CH Davos, ...", Stefan D Anker
Stefan D. Anker,"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","International journal of cardiology 86 (2-3), 123-130",507,2002,2,"SD Anker, AJS Coats",Stefan D Anker
Stefan D. Anker,Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors,"European heart journal 41 (19), 1810-1817",496,2020,18,"IE Sama, A Ravera, BT Santema, H van Goor, JM Ter Maaten, ...", Stefan D Anker
Stefan D. Anker,Intraventricular conduction delay: a prognostic marker in chronic heart failure,"International journal of cardiology 70 (2), 171-178",548,1999,7,"W Shamim, DP Francis, M Yousufuddin, S Varney, MF Pieopli, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol …,"Journal of the American College of Cardiology 53 (23), 2150-2158",569,2009,10,"DJ van Veldhuisen, A Cohen-Solal, M Böhm, SD Anker, D Babalis, ...", Stefan D Anker
Stefan D. Anker,"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","Nature Reviews Nephrology 12 (10), 610-623",573,2016,5,"JC Schefold, G Filippatos, G Hasenfuss, SD Anker, S Von Haehling", Stefan D Anker
Stefan D. Anker,Effect of empagliflozin on the clinical stability of patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial,"Circulation 143 (4), 326-336",332,2021,20,"M Packer, SD Anker, J Butler, G Filippatos, JP Ferreira, SJ Pocock, ...", Stefan D Anker
Stefan D. Anker,Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease,"Journal of cachexia, sarcopenia and muscle 2, 81-86",229,2011,9,"M Lainscak, S von Haehling, W Doehner, I Sarc, T Jeric, K Ziherl, ...", Stefan D Anker
Stefan D. Anker,The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle,"Journal of the American College of Cardiology 46 (10), 1799-1802",230,2005,5,"T Thum, J Bauersachs, PA Poole-Wilson, HD Volk, SD Anker", Stefan D Anker
Stefan D. Anker,Anemia and inflammation in COPD,"Chest 127 (3), 825-829",326,2005,6,"M John, S Hoernig, W Doehner, DD Okonko, C Witt, SD Anker", Stefan D Anker
Stefan D. Anker,A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease,"European heart journal 37 (27), 2105-2114",368,2016,17,"G Filippatos, SD Anker, M Böhm, M Gheorghiade, L Køber, H Krum, ...", Stefan D Anker
Stefan D. Anker,Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved …,"European journal of heart failure 21 (10), 1279-1287",230,2019,89,"SD Anker, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, ...",Stefan D Anker
Stefan D. Anker,Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes,"Circulation 143 (6), 540-552",231,2021,12,"G Filippatos, SD Anker, R Agarwal, B Pitt, LM Ruilope, P Rossing, ...", Stefan D Anker
Stefan D. Anker,Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension,"European heart journal 26 (18), 1895-1902",232,2005,12,"CF Opitz, R Wensel, J Winkler, M Halank, L Bruch, FX Kleber, G Höffken, ...", Stefan D Anker
Stefan D. Anker,Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart …,"European journal of heart failure 20 (1), 3-15",234,2018,15,"U Corra, PG Agostoni, SD Anker, AJS Coats, MG Crespo Leiro, ...", Stefan D Anker
Stefan D. Anker,Nutritional and anti-inflammatory interventions in chronic heart failure,"The American journal of cardiology 101 (11), S89-S103",232,2008,4,"K Kalantar-Zadeh, SD Anker, TB Horwich, GC Fonarow", Stefan D Anker
Stefan D. Anker,"Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation","Journal of the American College of Cardiology 32 (2), 393-397",240,1998,8,"J Niebauer, CD Pflaum, AL Clark, CJ Strasburger, J Hooper, ...", Stefan D Anker
Stefan D. Anker,"Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society …","European heart journal 39 (48), 4277-4284",240,2018,15,"B Zafrir, LH Lund, C Laroche, F Ruschitzka, MG Crespo-Leiro, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,Muscle wasting and sarcopenia in heart failure and beyond: update 2017,"ESC heart failure 4 (4), 492-498",236,2017,3,"J Springer, JI Springer, SD Anker", Stefan D Anker
Stefan D. Anker,Myocardial production of C-type natriuretic peptide in chronic heart failure,"Circulation 107 (4), 571-573",236,2003,7,"PR Kalra, JR Clague, AP Bolger, SD Anker, PA Poole-Wilson, ...", Stefan D Anker
Stefan D. Anker,Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica,,239,2021,2,"SE de Cardiología, Heart Failure Association",
Stefan D. Anker,ESPEN guidelines on enteral nutrition: cardiology and pulmonology,"Clinical Nutrition 25 (2), 311-318",241,2006,13,"SD Anker, M John, PU Pedersen, C Raguso, M Cicoira, E Dardai, ...",SD Anker
Stefan D. Anker,The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study,"European journal of heart failure 21 (8), 965-973",245,2019,21,"G Markousis‐Mavrogenis, J Tromp, W Ouwerkerk, M Devalaraja, ...", Stefan D Anker
Stefan D. Anker,Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study,"Circulation: heart failure 4 (5), 613-620",246,2011,28,"A Maisel, Y Xue, K Shah, C Mueller, R Nowak, WF Peacock, P Ponikowski, ...", Stefan D Anker
Stefan D. Anker,Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction,"Journal of the American College of Cardiology 72 (10), 1081-1090",249,2018,19,"J Tromp, BD Westenbrink, W Ouwerkerk, DJ van Veldhuisen, NJ Samani, ...", Stefan D Anker
Stefan D. Anker,"Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia","Journal of the American College of Cardiology 64 (11), 1092-1102",248,2014,15,"A Sandek, A Swidsinski, W Schroedl, A Watson, M Valentova, ...", Stefan D Anker
Stefan D. Anker,Oscillatory breathing patterns during wakefulness in patients with chronic heart failure: clinical implications and role of augmented peripheral chemosensitivity,"Circulation 100 (24), 2418-2424",250,1999,8,"P Ponikowski, SD Anker, TP Chua, D Francis, W Banasiak, ...", Stefan D Anker
Stefan D. Anker,Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference,"Kidney international 89 (1), 28-39",251,2016,54,"IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ...", Stefan D Anker
Stefan D. Anker,Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from ,"European heart journal 34 (20), 1489-1497",251,2013,11,"M Gheorghiade, GC Fonarow, DJ Van Veldhuisen, JGF Cleland, J Butler, ...", Stefan D Anker
Stefan D. Anker,"Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial","European journal of heart failure 17 (10), 1050-1056",185,2015,13,"SD Anker, M Kosiborod, F Zannad, IL Piña, PA McCullough, G Filippatos, ...",Stefan D Anker
Stefan D. Anker,Micronutrient deficiencies: an unmet need in heart failure,"Journal of the American College of Cardiology 54 (18), 1660-1673",183,2009,11,"V Soukoulis, JB Dihu, M Sole, SD Anker, J Cleland, GC Fonarow, M Metra, ...", Stefan D Anker
Stefan D. Anker,"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD-summary.",Diabetes and Vascular Disease Research 11 (3),181,2014,22,"L Ryden, PJ Grant, SD Anker, C Berne, F Cosentino, N Danchin, ...", Stefan D Anker
Stefan D. Anker,Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial,"International journal of cardiology 161 (3), 143-150",140,2012,15,"F Koehler, S Winkler, M Schieber, U Sechtem, K Stangl, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Interplay of mineralocorticoid receptor antagonists and empagliflozin in heart failure: EMPEROR-Reduced,"Journal of the American College of Cardiology 77 (11), 1397-1407",140,2021,11,"JP Ferreira, F Zannad, SJ Pocock, SD Anker, J Butler, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry,"JACC: Heart Failure 6 (6), 452-462",141,2018,10,"M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ...",
Stefan D. Anker,The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities …,"International journal of cardiology 205, 6-12",142,2016,16,"N Ebner, EA Jankowska, P Ponikowski, M Lainscak, S Elsner, V Sliziuk, ...", Stefan D Anker
Stefan D. Anker,The obesity paradox: weighing the benefit,"European heart journal 31 (2), 146-148",143,2010,3,"W Doehner, A Clark, SD Anker", Stefan D Anker
Stefan D. Anker,Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure),"JACC: Heart Failure 1 (3), 192-199",145,2013,20,"M Richards, S Di Somma, C Mueller, R Nowak, WF Peacock, ...", Stefan D Anker
Stefan D. Anker,Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI),"Cardiorenal Syndromes in Critical Care 165, 54-67",144,2010,28,"C Ronco, PA McCullough, SD Anker, I Anand, N Aspromonte, ...", Stefan D Anker
Stefan D. Anker,Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project),Bmj 377,146,2022,37,"R Bernabei, F Landi, R Calvani, M Cesari, S Del Signore, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST)","European heart journal 38 (22), 1749-1755",147,2017,10,"G Hindricks, N Varma, S Kacet, T Lewalter, P Søgaard, L Guedon-Moreau, ...", Stefan D Anker
Stefan D. Anker,Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review,"Journal of cachexia, sarcopenia and muscle 10 (1), 22-34",147,2019,11,"MS Anker, R Holcomb, M Muscaritoli, S von Haehling, W Haverkamp, ...",Markus S Anker
Stefan D. Anker,Muscle wasting in cardiac cachexia,"The international journal of biochemistry & cell biology 37 (10), 1938-1947",146,2005,3,"S Strassburg, J Springer, SD Anker", Stefan D Anker
Stefan D. Anker,Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure,"The American journal of cardiology 90 (4), 384-389",149,2002,9,"AP Bolger, R Sharma, S von Haehling, W Doehner, B Oliver, ...", Stefan D Anker
Stefan D. Anker,Insights into the pathogenesis of chronic heart failure: immune activation and cachexia,"Current opinion in cardiology 14 (3), 211",150,1999,2,"SD Anker, M Rauchhaus",Stefan D Anker
Stefan D. Anker,Circulating estradiol and mortality in men with systolic chronic heart failure,"Jama 301 (18), 1892-1901",150,2009,13,"EA Jankowska, P Rozentryt, B Ponikowska, O Hartmann, ...", Stefan D Anker
Stefan D. Anker,"Cachexia as a major public health problem: frequent, costly, and deadly","Journal of cachexia, sarcopenia and muscle 4, 173-178",150,2013,6,"J Farkas, S von Haehling, K Kalantar-Zadeh, JE Morley, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes","European heart journal 42 (6), 700-710",150,2021,27,"WT Abraham, JA Lindenfeld, P Ponikowski, P Agostoni, J Butler, AS Desai, ...", Stefan D Anker
Stefan D. Anker,"Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: the EMPEROR-Preserved trial","Circulation 145 (3), 184-193",156,2022,20,"J Butler, G Filippatos, T Jamal Siddiqi, M Brueckmann, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study,"International journal of cardiology 142 (3), 279-287",154,2010,12,"OJ Ekundayo, LJ Dell'Italia, PW Sanders, D Arnett, I Aban, TE Love, ...", Stefan D Anker
Stefan D. Anker,Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial,"American Journal of Nephrology 50 (5), 333-344",153,2019,11,"GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, C Nowack, P Kolkhof, ...", Stefan D Anker
Stefan D. Anker,"Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo …","Journal of cachexia, sarcopenia and muscle 7 (3), 355-365",151,2016,9,"AJ Stewart Coats, GF Ho, K Prabhash, S von Haehling, J Tilson, R Brown, ...", Stefan D Anker
Stefan D. Anker,"Rationale and design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR‐HF) study: a randomized, placebo‐controlled study of intravenous …","European journal of heart failure 11 (11), 1084-1091",140,2009,13,"SD Anker, JC Colet, G Filippatos, R Willenheimer, K Dickstein, H Drexler, ...",Stefan D Anker
Stefan D. Anker,Statin use and survival in patients with chronic heart failure—results from two observational studies with 5200 patients,"International journal of cardiology 112 (2), 234-242",136,2006,14,"SD Anker, AL Clark, R Winkler, C Zugck, M Cicoira, P Ponikowski, ...",Stefan D Anker
Stefan D. Anker,Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trials,"European Journal of Heart Failure 17 (4), 424-433",131,2015,14,"P Rossignol, S Masson, S Barlera, N Girerd, A Castelnovo, F Zannad, ...", Stefan D Anker
Stefan D. Anker,"Anaemia, iron deficiency and heart failure in 2020: facts and numbers","ESC heart failure 7 (5), 2007-2011",99,2020,2,"VK Chopra, SD Anker", Stefan D Anker
Stefan D. Anker,The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study,"European heart journal 42 (31), 3011-3020",99,2021,36,"EA Jankowska, BA Kirwan, M Kosiborod, J Butler, SD Anker, T McDonagh, ...", Stefan D Anker
Stefan D. Anker,Uric acid in chronic heart failure,"Seminars in nephrology 25 (1), 61-66",100,2005,2,"W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Galectin-3: a modifiable risk factor in heart failure,"Cardiovascular drugs and therapy 28, 237-246",100,2014,8,"RA de Boer, AR van der Velde, C Mueller, DJ van Veldhuisen, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Studies on intragastric PCO,"European journal of heart failure 6 (4), 403-407",101,2004,7,"A Krack, BM Richartz, A Gastmann, K Greim, U Lotze, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Guía de práctica clínica de la ESC sobre diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica 2012= ESC Guidelines for the diagnosis and treatment of acute …,"Revista Española de Cardiología 65 (10), 938",101,2012,66,"JJV McMurray, S Adamopoulos, SD Anker, A Auricchio, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Uric acid and xanthine oxidase in heart failure—Emerging data and therapeutic implications,"International journal of cardiology 213, 15-19",101,2016,5,"W Doehner, EA Jankowska, J Springer, M Lainscak, SD Anker", Stefan D Anker
Stefan D. Anker,Trends in prevalence of comorbidities in heart failure clinical trials,"European journal of heart failure 22 (6), 1032-1042",101,2020,9,"MS Khan, A Samman Tahhan, M Vaduganathan, SJ Greene, ...", Stefan D Anker
Stefan D. Anker,Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial,"European journal of heart failure 22 (12), 2383-2392",101,2020,39,"SD Anker, J Butler, G Filippatos, M Shahzeb Khan, JP Ferreira, E Bocchi, ...",Stefan D Anker
Stefan D. Anker,Bax JJ,"Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C …",102,2012,27,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency,"European Journal of Heart Failure 18 (5), 482-489",102,2016,32,"SD Anker, S Schroeder, D Atar, JJ Bax, C Ceconi, MR Cowie, A Crisp, ...",Stefan D Anker
Stefan D. Anker,Pathophysiology of peripheral muscle wasting in cardiac cachexia,"Current Opinion in Clinical Nutrition & Metabolic Care 8 (3), 249-254",103,2005,3,"GS Filippatos, SD Anker, DT Kremastinos", Stefan D Anker
Stefan D. Anker,Pharmacokinetics of drugs in cachectic patients: a systematic review,"PLOS one 8 (11), e79603",104,2013,6,"K Trobec, M Kerec Kos, S von Haehling, J Springer, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Heart Failure Association of the European Society of Cardiology heart failure nurse curriculum,"European journal of heart failure 18 (7), 736-743",103,2016,11,"JP Riley, F Astin, MG Crespo‐Leiro, CM Deaton, J Kienhorst, ...", Stefan D Anker
Stefan D. Anker,Growth hormone resistance in chronic heart failure and its therapeutic implications,"Journal of cardiac failure 9 (3), 219-226",105,2003,3,"M Cicoira, PR Kalra, SD Anker", Stefan D Anker
Stefan D. Anker,The gut and intestinal bacteria in chronic heart failure,"Current drug metabolism 10 (1), 22-28",105,2009,3,"A Sandek, SD Anker, S Haehling", Stefan D Anker
Stefan D. Anker,Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study,"European journal of heart failure 13 (6), 656-663",105,2011,9,"S von Haehling, DJ van Veldhuisen, M Roughton, D Babalis, RA de Boer, ...", Stefan D Anker
Stefan D. Anker,Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study‐Heart Failure (ARTS‐HF): a randomized study of finerenone vs. eplerenone in patients who have …,"European journal of heart failure 17 (2), 224-232",105,2015,15,"B Pitt, SD Anker, M Böhm, M Gheorghiade, L Køber, H Krum, AP Maggioni, ...", Stefan D Anker
Stefan D. Anker,Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes,"Journal of the American College of Cardiology 78 (2), 142-152",105,2021,14,"G Filippatos, GL Bakris, B Pitt, R Agarwal, P Rossing, LM Ruilope, J Butler, ...", Stefan D Anker
Stefan D. Anker,FIDELIO-DKD and FIGARO-DKD investigators. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled …,"Eur Heart J 43 (6), 474-484",105,2022,11,"R Agarwal, G Filippatos, B Pitt, SD Anker, P Rossing, A Joseph, P Kolkhof, ...", SD Anker
Stefan D. Anker,Time to move on from ‘time-to-first’: should all events be included in the analysis of clinical trials?,"European Heart Journal 33 (22), 2764-2765",106,2012,2,"SD Anker, JJV McMurray",Stefan D Anker
Stefan D. Anker,Request for regulatory guidance for cancer cachexia intervention trials,"Journal of cachexia, sarcopenia and muscle 6 (4), 272",106,2015,25,"KCH Fearon, JM Argiles, VE Baracos, R Bernabei, AJS Coats, J Crawford, ...", SD Anker
Stefan D. Anker,"Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future","Clinical Research in Cardiology 109, 1079-1098",106,2020,12,"J Wintrich, I Kindermann, C Ukena, S Selejan, C Werner, C Maack, ...", Stefan D Anker
Stefan D. Anker,Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT‐CHF,"European journal of heart failure 19 (10), 1284-1293",99,2017,20,"JP Ferreira, P Rossignol, JL Machu, A Sharma, N Girerd, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches,"Current heart failure reports 2 (4), 198-203",98,2005,3,"YJ Akashi, J Springer, SD Anker", Stefan D Anker
Stefan D. Anker,ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the …,"Eur Heart J 37 (27), 2129-2200",95,2016,22,"AJS Coats, B Pieske, C Linde, EA Jankowska, F Ruschitzka, FH Rutten, ...", SD Anker
Stefan D. Anker,Iron deficiency and cardiovascular disease,"European heart journal 44 (1), 14-27",78,2023,6,"G Savarese, S von Haehling, J Butler, JGF Cleland, P Ponikowski, ...", Stefan D Anker
Stefan D. Anker,"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","PLoS One 6 (11), e26865",70,2011,11,"S Palus, R Schur, YJ Akashi, B Bockmeyer, R Datta, H Halem, J Dong, ...", Stefan D Anker
Stefan D. Anker,Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium–glucose cotransporter 2 inhibitor treatment: the FIDELITY analysis,"Diabetes Care 45 (12), 2991-2998",71,2022,14,"P Rossing, SD Anker, G Filippatos, B Pitt, LM Ruilope, AL Birkenfeld, ...", Stefan D Anker
Stefan D. Anker,The incremental prognostic and clinical value of multiple novel biomarkers in heart failure,"European journal of heart failure 18 (12), 1491-1498",69,2016,12,"CE Jackson, C Haig, P Welsh, JR Dalzell, IK Tsorlalis, A McConnachie, ...", Stefan D Anker
Stefan D. Anker,Ferritin levels and risk of heart failure—the Atherosclerosis Risk in Communities Study,"European journal of heart failure 19 (3), 340-347",70,2017,9,"OM Silvestre, A Gonçalves, W Nadruz Jr, B Claggett, D Couper, ...", Stefan D Anker
Stefan D. Anker,Cachexia as major underestimated unmet medical need: facts and numbers,"International journal of cardiology 161 (3), 121-123",69,2012,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,"Concentric vs. eccentric remodelling in heart failure with reduced ejection fraction: clinical characteristics, pathophysiology and response to treatment","European journal of heart failure 22 (7), 1147-1155",70,2020,20,"JF Nauta, YM Hummel, J Tromp, W Ouwerkerk, P van der Meer, X Jin, ...", Stefan D Anker
Stefan D. Anker,Expert opinion paper on atrial fibrillation detection after ischemic stroke,"Clinical Research in Cardiology 107, 871-880",71,2018,26,"KG Haeusler, K Groeschel, M Koehrmann, SD Anker, J Brachmann, ...", Stefan D Anker
Stefan D. Anker,The role of C-type natriuretic peptide in cardiovascular medicine,"European heart journal 22 (12), 997-1007",72,2001,4,"PR Kalra, SD Anker, AD Struthers, AJS Coats", SD Anker
Stefan D. Anker,"Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview","Archives of Medical Science 14 (4), 890-909",72,2018,6,"M Michalska-Kasiczak, A Bielecka-Dabrowa, S Von Haehling, SD Anker, ...", Stefan D Anker
Stefan D. Anker,The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure,"Wiener Klinische Wochenschrift 121, 309-313",73,2009,7,"M Lainscak, LM Hodoscek, HD Düngen, M Rauchhaus, W Doehner, ...", Stefan D Anker
Stefan D. Anker,"The ACT‐ONE trial, a multicentre, randomised, double‐blind, placebo‐controlled, dose‐finding study of the anabolic/catabolic transforming agent, MT‐102 in subjects with …","Journal of Cachexia, Sarcopenia and Muscle 2 (4), 201-207",73,2011,15,"AJ Stewart Coats, V Srinivasan, J Surendran, H Chiramana, ...", Stefan D Anker
Stefan D. Anker,Treatment of cachexia: an overview of recent developments,"International journal of cardiology 184, 736-742",73,2015,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Potassium and the use of renin–angiotensin–aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT‐CHF,"European journal of heart failure 20 (5), 923-930",73,2018,20,"JC Beusekamp, J Tromp, HH van der Wal, SD Anker, JG Cleland, ...", Stefan D Anker
Stefan D. Anker,"Association of rivaroxaban with thromboembolic events in patients with heart failure, coronary disease, and sinus rhythm: a post hoc analysis of the COMMANDER HF trial","JAMA cardiology 4 (6), 515-523",73,2019,15,"B Greenberg, JD Neaton, SD Anker, WM Byra, JGF Cleland, H Deng, ...", Stefan D Anker
Stefan D. Anker,Catecholamine levels and treatment in chronic heart failure.,"European heart journal 19, F56-61",74,1998,1,SD Anker,SD Anker
Stefan D. Anker,Studies on apoptosis and fibrosis in skeletal musculature: a comparison of heart failure patients with and without cardiac cachexia,"International journal of cardiology 90 (1), 107-113",75,2003,9,"GS Filippatos, C Kanatselos, DD Manolatos, B Vougas, A Sideris, ...", Stefan D Anker
Stefan D. Anker,Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies,"Journal of cachexia, sarcopenia and muscle 5, 27-34",75,2014,5,"N Ebner, L Steinbeck, W Doehner, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency,"Eur Heart J 36 (11), 657-668",75,2015,15,"P Ponikowski, DJ Van Veldhuisen, J Comin-Colet, G Ertl, M Komajda, ...", SD Anker
Stefan D. Anker,2016ESC Guidelinesforthediagnosisandtreatmentofacute andchronicheartfailure …,"EurHeartJ 37 (27), 2129",75,2016,2,"VAA PonikowskiP, SD Anker", SD Anker
Stefan D. Anker,Iron status and survival in diabetic patients with coronary artery disease,"Diabetes care 36 (12), 4147-4156",76,2013,12,"B Ponikowska, T Suchocki, B Paleczny, M Olesinska, S Powierza, ...", Stefan D Anker
Stefan D. Anker,Iron therapy in anaemic adults without chronic kidney disease,Cochrane Database of Systematic Reviews,76,2014,5,"KS Gurusamy, M Nagendran, JF Broadhurst, SD Anker, T Richards", Stefan D Anker
Stefan D. Anker,In‐hospital worsening heart failure,"European journal of heart failure 17 (11), 1104-1113",76,2015,17,"J Butler, M Gheorghiade, A Kelkar, GC Fonarow, S Anker, SJ Greene, ...", Stefan Anker
Stefan D. Anker,"Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference: Barcelona, Spain, 5–8 December 2009","Expert opinion on investigational drugs 19 (4), 579-585",77,2010,5,"T Kung, J Springer, W Doehner, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the …,"Thrombosis and haemostasis 108 (6), 1009-1022",69,2012,11,"GY Lip, P Piotrponikowski, F Andreotti, SD Anker, G Filippatos, S Homma, ...", Stefan D Anker
Stefan D. Anker,Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries,"International journal of cardiology 167 (1), 63-66",67,2013,8,"O Tutarel, S Dangwal, J Bretthauer, M Westhoff-Bleck, P Roentgen, ...", Stefan D Anker
Stefan D. Anker,"The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection …",EuroIntervention 15 (5),64,2019,12,"C Paitazoglou, R Özdemir, R Pfister, M Bergmann, J Bartunek, T Kilic, ...", Stefan Anker
Stefan D. Anker,Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial,"American Heart Journal 253, 86-98",63,2022,11,"J Harrington, JA Udell, WS Jones, SD Anker, DL Bhatt, MC Petrie, ...", Stefan D Anker
Stefan D. Anker,Impact of renal impairment on beta-blocker efficacy in patients with heart failure,"Journal of the American College of Cardiology 74 (23), 2893-2904",63,2019,23,"D Kotecha, SK Gill, MD Flather, J Holmes, M Packer, G Rosano, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Differences in clinical profile and outcomes of low iron storage vs defective iron utilization in patients with heart failure: results from the DEFINE-HF and BIOSTAT-CHF studies,"JAMA cardiology 4 (7), 696-701",61,2019,9,"NG Beverborg, HH van der Wal, IJT Klip, SD Anker, J Cleland, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Task Force for the D,,58,2012,26,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Bohm, ...", SD Anker
Stefan D. Anker,Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1,"PloS one 6 (1), e14506",57,2011,16,"EA Jankowska, GS Filippatos, S von Haehling, J Papassotiriou, ...", Stefan D Anker
Stefan D. Anker,"Rationale and design of the DIGIT‐HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double‐blind, placebo‐controlled study","European journal of heart failure 21 (5), 676-684",54,2019,39,"U Bavendiek, D Berliner, LA Dávila, J Schwab, L Maier, SA Philipp, ...", Stefan Anker
Stefan D. Anker,Application of the reverse fragility index to statistically nonsignificant randomized clinical trial results,"JAMA Network Open 3 (8), e2012469-e2012469",54,2020,8,"MS Khan, GC Fonarow, T Friede, N Lateef, SU Khan, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Weight-change as a prognostic marker in 12 550 patients following acute myocardial infarction or with stable coronary artery disease,"European heart journal 27 (23), 2755-2762",55,2006,7,"LMA Kennedy, K Dickstein, SD Anker, M James, TJ Cook, K Kristianson, ...", Stefan D Anker
Stefan D. Anker,"Worsening of chronic heart failure: Definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society …","European Journal of Heart Failure 25 (6), 776-791",54,2023,40,"M Metra, D Tomasoni, M Adamo, A Bayes‐Genis, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes,"Circulation 146 (9), 676-686",54,2022,14,"G Filippatos, J Butler, D Farmakis, F Zannad, AP Ofstad, JP Ferreira, ...", Stefan D Anker
Stefan D. Anker,No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure,"International Journal of Cardiology 137 (3), 267-275",55,2009,11,"YJ Akashi, S Palus, R Datta, H Halem, JE Taylor, C Thoene-Reineke, ...", Stefan D Anker
Stefan D. Anker,Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction,"Circulation: Heart Failure 7 (6), 945-952",55,2014,10,"K Patel, GC Fonarow, M Ahmed, C Morgan, M Kilgore, TE Love, ...", Stefan D Anker
Stefan D. Anker,ESC-HFA HF Long-Term Registry investigators. In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart …,"Eur J Heart Fail 19 (1), 54-65",55,2017,16,"G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ...", S Anker
Stefan D. Anker,Cardiorenal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative,"Europ. Heart J 31, 703-11",55,2010,2,"CP Ronco С, SD Anker", SD Anker
Stefan D. Anker,Orthostatic hypotension and incident heart failure in community-dwelling older adults,Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …,55,2014,13,"K Alagiakrishnan, K Patel, RV Desai, MB Ahmed, GC Fonarow, ...", Stefan D Anker
Stefan D. Anker,The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure,"Clinical Research in Cardiology 109, 331-338",55,2020,24,"BT Santema, MMY Chan, J Tromp, M Dokter, HH van Der Wal, ...", Stefan D Anker
Stefan D. Anker,SGLT2 inhibitors and cardiac remodelling: a systematic review and meta‐analysis of randomized cardiac magnetic resonance imaging trials,"ESC heart failure 8 (6), 4693-4700",55,2021,7,"NK Dhingra, N Mistry, P Puar, R Verma, S Anker, CD Mazer, S Verma", Stefan Anker
Stefan D. Anker,Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure,"PLoS One 4 (7), e6411",56,2009,10,"S von Haehling, JC Schefold, E Jankowska, W Doehner, J Springer, ...", Stefan D Anker
Stefan D. Anker,Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: ,"Journal of the American College of Cardiology 79 (20), 2058-2068",55,2022,8,"JA Udell, WS Jones, MC Petrie, J Harrington, SD Anker, DL Bhatt, ...", Stefan D Anker
Stefan D. Anker,Comparative assessment of short-term adverse events in acute heart failure with cystatin C and other estimates of renal function: results from the ASCEND-HF trial,"JACC: Heart Failure 3 (1), 40-49",56,2015,17,"WHW Tang, M Dupont, AF Hernandez, AA Voors, AP Hsu, GM Felker, ...", Stefan D Anker
Stefan D. Anker,IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia,"Journal of cachexia, sarcopenia and muscle 2, 105-109",57,2011,6,"K Schmidt, S von Haehling, W Doehner, S Palus, SD Anker, J Springer", Stefan D Anker
Stefan D. Anker,"Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology","European Journal of Heart Failure 24 (10), 1751-1766",56,2022,43,"J Núñez, R de la Espriella, P Rossignol, AA Voors, W Mullens, M Metra, ...", Stefan D Anker
Stefan D. Anker,Development and validation of cardiovascular risk scores for haemodialysis patients,"International journal of cardiology 216, 68-77",57,2016,13,"SD Anker, IA Gillespie, KU Eckardt, F Kronenberg, S Richards, TB Drueke, ...",Stefan D Anker
Stefan D. Anker,"EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)—EURObservational Research Program of …","European Heart Journal-Cardiovascular Imaging 16 (5), 466-470",54,2015,11,"P Lancellotti, SD Anker, E Donal, T Edvardsen, BA Popescu, D Farmakis, ...", Stefan D Anker
Stefan D. Anker,Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia,"International journal of cardiology 168 (4), 3412-3418",52,2013,7,"S Palus, S von Haehling, VC Flach, A Tschirner, W Doehner, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Increased catabolic activity in adipose tissue of patients with chronic heart failure,"European journal of heart failure 15 (10), 1131-1137",52,2013,9,"T Szabó, E Postrach, A Mähler, T Kung, G Turhan, S von Haehling, ...", Stefan D Anker
Stefan D. Anker,Liver dysfunction and its nutritional implications in heart failure,"Nutrition 29 (2), 370-378",52,2013,6,"M Valentová, S von Haehling, W Doehner, J Murín, SD Anker, A Sandek", Stefan D Anker
Stefan D. Anker,A cost-effectiveness analysis of ferric carboxymaltose in patients with iron deficiency and chronic heart failure in Spain,"Revista Española de Cardiología (English Edition) 68 (10), 846-851",43,2015,7,"J Comín-Colet, D Rubio-Rodríguez, C Rubio-Terres, C Enjuanes-Grau, ...", Stefan D Anker
Stefan D. Anker,Dietary interventions and nutritional supplements for heart failure: a systematic appraisal and evidence map,"European Journal of Heart Failure 23 (9), 1468-1476",40,2021,11,"MS Khan, F Khan, GC Fonarow, J Sreenivasan, SJ Greene, SU Khan, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc …,"The Lancet Diabetes & Endocrinology 10 (1), 35-45",40,2022,150,"S Verma, NK Dhingra, J Butler, SD Anker, JP Ferreira, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Evidence for partial pharmaceutical reversal of the cancer anorexia–cachexia syndrome: the case of anamorelin,"Journal of Cachexia, Sarcopenia and Muscle 6 (4), 275-277",40,2015,3,"SD Anker, AJS Coats, JE Morley",Stefan D Anker
Stefan D. Anker,"Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.","Herz 34 (2), 141-147",40,2009,2,"M Lainscak, SD Anker", Stefan D Anker
Stefan D. Anker,Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension,"International journal of cardiology 144 (2), 206-211",40,2010,10,"S von Haehling, RS von Bardeleben, T Kramm, Y Thiermann, ...", Stefan D Anker
Stefan D. Anker,Hormonal consequences and prognosis of chronic heart failure,"Current Opinion in Endocrinology, Diabetes and Obesity 18 (3), 224-230",40,2011,4,"P Attanasio, SD Anker, W Doehner, S von Haehling", Stefan D Anker
Stefan D. Anker,Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly,"International journal of cardiology 155 (1), 160-166",40,2012,11,"G Gelbrich, F Edelmann, S Inkrot, M Lainscak, S Apostolovic, ...", Stefan D Anker
Stefan D. Anker,Models of sarcopenia: Short review,"International journal of cardiology 238, 19-21",40,2017,7,"S Palus, JI Springer, W Doehner, S von Haehling, M Anker, SD Anker, ...", M Anker
Stefan D. Anker,The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR‐HF study,"European journal of heart failure 15 (7), 756-762",40,2013,7,"EM Van Craenenbroeck, VM Conraads, N Greenlaw, G Gaudesius, ...", Stefan D Anker
Stefan D. Anker,Suppression of erythropoiesis in patients with chronic heart failure and anaemia of unknown origin: evidence of an immune basis,"International journal of cardiology 166 (3), 664-671",40,2013,5,"DO Okonko, SB Marley, SD Anker, PA Poole-Wilson, MY Gordon", Stefan D Anker
Stefan D. Anker,Biomarker-guided versus guideline-based treatment of patients with heart failure: results from BIOSTAT-CHF,"Journal of the American College of Cardiology 71 (4), 386-398",40,2018,18,"W Ouwerkerk, AH Zwinderman, LL Ng, B Demissei, HL Hillege, F Zannad, ...", Stefan D Anker
Stefan D. Anker,Body weight changes and incidence of cachexia after stroke,"Journal of cachexia, sarcopenia and muscle 10 (3), 611-620",40,2019,12,"N Scherbakov, C Pietrock, A Sandek, N Ebner, M Valentova, J Springer, ...", Stefan D Anker
Stefan D. Anker,Acute decompensated heart failure in the setting of acute coronary syndrome,"Heart failure 10 (6), 404-414",40,2022,10,"J Harrington, WS Jones, JA Udell, K Hannan, DL Bhatt, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology …,"Journal of Cardiac Failure 29 (5), 787-804",40,2023,28,"H Tsutsui, NM Albert, AJS Coats, SD Anker, A Bayes-Genis, J Butler, ...", Stefan D Anker
Stefan D. Anker,Impaired insulin sensitivity as an underlying mechanism linking hepatitis C and posttransplant diabetes mellitus in kidney recipients,"American Journal of Transplantation 9 (12), 2777-2784",41,2009,10,"S Baid-Agrawal, U Frei, P Reinke, R Schindler, MA Kopp, P Martus, ...", Stefan D Anker
Stefan D. Anker,Toll-like receptor modulation in cardiovascular disease: a target for intervention?,"Expert Opinion on Investigational Drugs 15 (8), 857-871",41,2006,3,"G Földes, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the …,"Clinical pharmacology & therapeutics 88 (4), 506-512",41,2010,10,"S Von Haehling, SM Bode‐Böger, J Martens‐Lobenhoffer, M Rauchhaus, ...", SD Anker
Stefan D. Anker,Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference,"International journal of cardiology 144 (3), 347-349",41,2010,3,"S von Haehling, R Stepney, SD Anker", Stefan D Anker
Stefan D. Anker,Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events,"International journal of cardiology 168 (3), 1905-1909",41,2013,14,"K Patel, X Sui, Y Zhang, GC Fonarow, IB Aban, CJ Brown, V Bittner, ...", Stefan D Anker
Stefan D. Anker,Systolic–diastolic hypertension versus isolated systolic hypertension and incident heart failure in older adults: Insights from the Cardiovascular Health Study,"International journal of cardiology 235, 11-16",41,2017,20,"A Tsimploulis, HM Sheriff, PH Lam, DJ Dooley, MS Anker, ...", Markus S Anker
Stefan D. Anker,"Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle","ESC heart failure 5 (4), 549-551",41,2018,2,"SD Anker, J Butler",Stefan D Anker
Stefan D. Anker,The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy,"International journal of cardiology 168 (4), 3527-3531",41,2013,6,"J Springer, A Tschirner, K Hartman, S von Haehling, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data","American journal of nephrology 48 (4), 260-268",41,2018,14,"IC Macdougall, C White, SD Anker, S Bhandari, K Farrington, PA Kalra, ...", Stefan D Anker
Stefan D. Anker,Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial,"European heart journal 42 (43), 4442-4451",41,2021,16,"CSP Lam, JP Ferreira, E Pfarr, D Sim, H Tsutsui, SD Anker, J Butler, ...", Stefan D Anker
Stefan D. Anker,Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO‐DKD trial,"European Journal of Heart Failure 24 (6), 996-1005",39,2022,14,"G Filippatos, B Pitt, R Agarwal, D Farmakis, LM Ruilope, P Rossing, ...", Stefan D Anker
Stefan D. Anker,Systemically measured cytokines are independently predictive for increased mortality in patients with chronic heart failure,"JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 35 (2), 224A-224A",39,2000,7,"M Rauchhaus, W Doehner, V Koloczek, J Niebauer, DP Francis, ...", SD Anker
Stefan D. Anker,"Ehra expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the heart rhythm society (hrs), asia pacific heart rhythm society (aphrs …","Europace 25 (4), 1249-1276",37,2023,35,"I Savelieva, S Fumagalli, RA Kenny, S Anker, A Benetos, G Boriani, ...", Stefan Anker
Stefan D. Anker,Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries,"American heart journal 168 (2), 142-149",37,2014,18,"SJ Greene, AN Shah, J Butler, AP Ambrosy, SD Anker, O Chioncel, ...", Stefan D Anker
Stefan D. Anker,Cardio-renal anemia syndrome,"Hemodialysis 171, 266-273",37,2011,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Procalcitonin-guided antibiotic treatment in heart failure,"The Lancet 363 (9420), 1555-1556",37,2004,4,"M Christ-Crain, D Jaccard-Stolz, M Tamm, B Müller",
Stefan D. Anker,Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial,"Cerebrovascular Diseases 38 (3), 176-181",33,2014,18,"PM Pullicino, M Qian, RL Sacco, R Freudenberger, S Graham, ...", Stefan D Anker
Stefan D. Anker,Three year mortality in heart failure patients with very low left ventricular ejection fractions,"International journal of cardiology 70 (3), 245-247",33,1999,4,"J Niebauer, AL Clark, SD Anker, AJS Coats", SD Anker
Stefan D. Anker,ESC-HFA Heart Failure Long-Term Registry. Association between diabetes and 1-year adverse clinical outcomes in a multinational cohort of ambulatory patients with chronic heart …,"Diabetes Care 40 (5), 671-678",32,2017,13,"M Dauriz, G Targher, C Laroche, PL Temporelli, R Ferrari, S Anker, ...", S Anker
Stefan D. Anker,Blood pressure and cardiorenal outcomes with finerenone in chronic kidney disease in type 2 diabetes,"Hypertension 79 (12), 2685-2695",31,2022,13,"LM Ruilope, R Agarwal, SD Anker, G Filippatos, B Pitt, P Rossing, ...", Stefan D Anker
Stefan D. Anker,Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: ,"Journal of the American College of Cardiology 77 (19), 2432-2447",30,2021,11,"PB Parikh, DL Bhatt, V Bhasin, SD Anker, HA Skopicki, BE Claessen, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin improves outcomes in patients with heart failure and preserved ejection fraction irrespective of age,"Journal of the American College of Cardiology 80 (1), 1-18",29,2022,16,"M Böhm, J Butler, G Filippatos, JP Ferreira, SJ Pocock, A Abdin, ...", Stefan D Anker
Stefan D. Anker,Albuminuria as a marker of systemic congestion in patients with heart failure,"European Heart Journal 44 (5), 368-380",29,2023,19,"EM Boorsma, JM Ter Maaten, K Damman, BJ van Essen, F Zannad, ...", Stefan D Anker
Stefan D. Anker,Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease,"Internal Medicine 45 (13), 837-837",30,2006,5,"M Lainscak, S Andreas, PD Scanlon, VK Somers, SD Anker", Stefan D Anker
Stefan D. Anker,Febuxostat improves outcome in a rat model of cancer cachexia,"Journal of Cachexia, Sarcopenia and Muscle 6 (2), 174-180",30,2015,9,"M Konishi, L Pelgrim, A Tschirner, A Baumgarten, S von Haehling, ...", Stefan D Anker
Stefan D. Anker,Similar clinical benefits from below‐target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial,"European journal of heart failure 20 (2), 359-369",30,2018,21,"PH Lam, DJ Dooley, GC Fonarow, J Butler, DL Bhatt, GS Filippatos, ...", Stefan D Anker
Stefan D. Anker,Geographical location affects the levels and association of trimethylamine N-oxide with heart failure mortality in BIOSTAT-CHF: a post-hoc analysis,"European journal of heart failure 21 (10), 1291-1294",30,2019,11,"Y Yazaki, A Salzano, CP Nelson, AA Voors, SD Anker, JG Cleland, ...", Stefan D Anker
Stefan D. Anker,Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction,"Clinical Research in Cardiology 109, 1048-1059",30,2020,17,"JM Ter Maaten, P Martens, K Damman, K Dickstein, P Ponikowski, ...", Stefan D Anker
Stefan D. Anker,Guidance on the management of left ventricular assist device (LVAD) supported patients for the non‐LVAD specialist healthcare provider: executive summary,"European journal of heart failure 23 (10), 1597-1609",30,2021,41,"T Ben Gal, B Ben Avraham, D Milicic, MG Crespo‐Leiro, AJS Coats, ...", Stefan Anker
Stefan D. Anker,Prognostic implications of N-Terminal Pro–B-type natriuretic peptide and high-sensitivity cardiac troponin T in EMPEROR-Preserved,"Heart Failure 10 (7), 512-524",30,2022,14,"JL Januzzi Jr, J Butler, F Zannad, G Filippatos, JP Ferreira, SJ Pocock, ...", Stefan D Anker
Stefan D. Anker,Uric acid in CHF: marker or player in a metabolic disease?,"International journal of cardiology 115 (2), 156-158",31,2007,3,"W Doehner, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Anemia in heart failure: an overview of current concepts,"Future Cardiology 7 (1), 119-129",31,2011,4,"S Von Haehling, EA Jankowska, P Ponikowski, SD Anker", Stefan D Anker
Stefan D. Anker,Proteomic diversity of high‐density lipoprotein explains its association with clinical outcome in patients with heart failure,"European journal of heart failure 20 (2), 260-267",31,2018,21,"JE Emmens, DJL Jones, TH Cao, DCS Chan, SPR Romaine, PA Quinn, ...", Stefan D Anker
Stefan D. Anker,Adherence to treatment guidelines and long‐term survival in hospitalized patients with chronic obstructive pulmonary disease,"Journal of evaluation in clinical practice 17 (4), 737-743",31,2011,7,"I Sarc, T Jeric, K Ziherl, S Suskovic, M Kosnik, SD Anker, M Lainscak", Stefan D Anker
Stefan D. Anker,"Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference","Journal of Cachexia, Sarcopenia and Muscle 10 (1), 218-225",31,2019,3,"N Ebner, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,Heart failure epidemiology in patients with diabetes mellitus without coronary heart disease,"Journal of Cardiac Failure 25 (2), 78-86",31,2019,7,"H Khan, SD Anker, JL Januzzi Jr, DK McGuire, N Sattar, HJ Woerle, ...", Stefan D Anker
Stefan D. Anker,Tumour biomarkers: association with heart failure outcomes,"Journal of Internal Medicine 288 (2), 207-218",31,2020,23,"C Shi, HH van der Wal, HHW Silljé, MM Dokter, F van den Berg, ...", Stefan D Anker
Stefan D. Anker,Distinct pathological pathways in patients with heart failure and diabetes,"Heart Failure 8 (3), 234-242",31,2020,18,"J Tromp, AA Voors, A Sharma, JP Ferreira, W Ouwerkerk, HL Hillege, ...", Stefan D Anker
Stefan D. Anker,Effects of rivaroxaban on biomarkers of coagulation and inflammation: a post hoc analysis of the X-VeRT trial,"TH Open 4 (01), e20-e32",31,2020,10,"P Kirchhof, MD Ezekowitz, Y Purmah, S Schiffer, IL Meng, AJ Camm, ...", Stefan H Hohnloser
Stefan D. Anker,The need for increased pragmatism in cardiovascular clinical trials,"Nature Reviews Cardiology 19 (11), 737-750",31,2022,13,"MS Usman, HGC Van Spall, SJ Greene, A Pandey, DK McGuire, ZA Ali, ...", Stefan D Anker
Stefan D. Anker,A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease,"Clinical kidney journal 16 (2), 293-302",31,2023,17,"R Agarwal, B Pitt, BF Palmer, CP Kovesdy, E Burgess, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Metabolic and immunologic derangements in cardiac cachexia: where to from here?,"Heart failure reviews 11, 57-64",32,2006,2,"S Strassburg, SD Anker", Stefan D Anker
Stefan D. Anker,Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia,"Nutrition 30 (9), 1069-1075",28,2014,8,"K Trobec, S Palus, A Tschirner, S von Haehling, W Doehner, M Lainscak, ...", Stefan D Anker
Stefan D. Anker,Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study,"European journal of clinical pharmacology 72, 813-822",28,2016,8,"K Cvan Trobec, I Grabnar, M Kerec Kos, T Vovk, J Trontelj, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Early initiation of SGLT2 inhibitors is important, irrespective of ejection fraction: SOLOIST‐WHF in perspective","ESC Heart Failure 7 (6), 3261-3267",25,2020,4,"S Verma, SD Anker, J Butler, DL Bhatt", Stefan D Anker
Stefan D. Anker,"Coronary angiography in worsening heart failure: determinants, findings and prognostic implications","Heart 104 (7), 606-613",27,2018,19,"JP Ferreira, P Rossignol, B Demissei, A Sharma, N Girerd, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial,"European Journal of Heart Failure 24 (10), 1869-1878",25,2022,13,"SJ Pocock, JP Ferreira, M Packer, F Zannad, G Filippatos, T Kondo, ...", Stefan D Anker
Stefan D. Anker,Wytyczne ESC/ESA dotyczace operacji niekardiochirurgicznych-ocena ryzyka sercowo-naczyniowego i postepowanie w 2014 roku.,Kardiologia Polska 72 (11),25,2014,24,"SD Kristensen, J Knuuti, A Saraste, S Anker, HE Botker, S De Hert, I Ford, ...", Stefan Anker
Stefan D. Anker,Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR‐Reduced,"European journal of heart failure 25 (1), 117-127",24,2023,14,"SD Anker, MS Khan, J Butler, AP Ofstad, B Peil, E Pfarr, W Doehner, ...",Stefan D Anker
Stefan D. Anker,Neuromuscular electrical stimulation for muscle wasting in heart failure patients,"International journal of cardiology 225, 200-205",24,2016,6,"M Saitoh, MR Dos Santos, M Anker, SD Anker, S von Haehling, J Springer", Markus Anker
Stefan D. Anker,Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF,"European journal of internal medicine 71, 62-69",22,2020,15,"M Kobayashi, AA Voors, N Girerd, M Billotte, SD Anker, JG Cleland, ...", Stefan D Anker
Stefan D. Anker,Prognostic importance of anaemia in patients with acute pulmonary embolism,"Thrombosis and haemostasis 106 (08), 289-295",22,2011,5,"J Donzé, J Labarère, M Méan, D Jiménez, D Aujesky",
Stefan D. Anker,Genetic risk and atrial fibrillation in patients with heart failure,"European Journal of Heart Failure 22 (3), 519-527",21,2020,23,"M Kloosterman, BT Santema, C Roselli, CP Nelson, A Koekemoer, ...", Stefan Anker
Stefan D. Anker,Head‐to‐head comparison between recommendations by the ESC and ACC/AHA/HFSA heart failure guidelines,"European Journal of Heart Failure 24 (6), 916-926",21,2022,11,"A Bayés‐Genís, A Aimo, M Metra, S Anker, P Seferovic, C Rapezzi, ...", Stefan Anker
Stefan D. Anker,Association of empagliflozin treatment with albuminuria levels in patients with heart failure: a secondary analysis of EMPEROR-Pooled,"JAMA cardiology 7 (11), 1148-1159",21,2022,10,"JP Ferreira, F Zannad, J Butler, G Filippatos, SJ Pocock, M Brueckmann, ...", Stefan D Anker
Stefan D. Anker,Chronic heart failure as a metabolic disorder.,"Heart Failure Monitor 1 (2), 42-49",22,2000,2,"SD Anker, FO Al-Nasser",SD Anker
Stefan D. Anker,Defects in insulin action in chronic heart failure.,"Diabetes, Obesity & Metabolism 2 (4)",22,2000,3,"W Doehner, SD Anker, AJS Coats", Stefan D Anker
Stefan D. Anker,AHA Journals,Circulation 103 (12),22,2001,100,"P Coats, F Johnston, J MacDonald, C Hillier, LM Godsel, K Wang, ...",
Stefan D. Anker,Revisiting the obesity paradox in heart failure: new insights?,"European journal of heart failure 13 (2), 130-132",22,2011,3,"S von Haehling, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model,"International journal of cardiology 168 (3), 2369-2374",22,2013,9,"S Palus, S von Haehling, W Doehner, R Datta, J Zhang, JZ Dong, ...", Stefan D Anker
Stefan D. Anker,Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term …,"European Journal of Internal Medicine 89, 65-75",22,2021,16,"G Ambrosio, MGC Leiro, LH Lund, S Coiro, A Cardona, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Isolated diastolic hypertension and incident heart failure in community-dwelling older adults: insights from the Cardiovascular Health Study,"International journal of cardiology 238, 140-143",22,2017,15,"HM Sheriff, A Tsimploulis, M Valentova, MS Anker, P Deedwania, ...", Markus S Anker
Stefan D. Anker,Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock,"European Journal of Heart Failure 24 (9), 1573-1582",22,2022,15,"FL Scolari, S Abelson, DH Brahmbhatt, JJF Medeiros, CPS Fan, NL Fung, ...", Markus S Anker
Stefan D. Anker,"Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence","ESC Heart Failure 9 (6), 4167-4176",22,2022,21,"V Bracun, B van Essen, AA Voors, DJ van Veldhuisen, K Dickstein, ...", Stefan Anker
Stefan D. Anker,Depressed heart rate variability is an independent predictor of death in patients with chronic heart failure,"Eur. Heart J 18 (S), 577",23,1997,3,"P Ponikovski, S Anker, T Chua", S Anker
Stefan D. Anker,Metabolic disturbances in chronic heart failure: a case for the “macho” approach with testosterone?!,"European journal of heart failure 9 (1), 2-3",23,2007,3,"M Lainscak, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart …,"Journal of the American Medical Directors Association 14 (11), 837-841",23,2013,11,"M Tacke, N Ebner, M Boschmann, A Jarius, M Valentova, S Fülster, ...", Stefan D Anker
Stefan D. Anker,Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction …,"Circulation: Heart Failure 8 (3), 504-509",23,2015,20,"S Homma, JLP Thompson, M Qian, S Ye, MR Di Tullio, GYH Lip, DL Mann, ...", Stefan D Anker
Stefan D. Anker,Natriuretic peptide-based inclusion criteria in a heart failure clinical trial: insights from COMMANDER HF,"Heart Failure 8 (5), 359-368",23,2020,15,"JW Cunningham, JP Ferreira, H Deng, SD Anker, WM Byra, JGF Cleland, ...", Stefan D Anker
Stefan D. Anker,Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA,"Diabetes Care 45 (4), e888-e897",23,2022,15,"P Rossing, E Burgess, R Agarwal, SD Anker, G Filippatos, B Pitt, ...", Stefan D Anker
Stefan D. Anker,Remote speech analysis in the evaluation of hospitalized patients with acute decompensated heart failure,"Heart Failure 10 (1), 41-49",23,2022,10,"O Amir, WT Abraham, ZS Azzam, G Berger, SD Anker, SP Pinney, ...", Stefan D Anker
Stefan D. Anker,"Cardiac remodelling–Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of …","European journal of heart failure 24 (6), 944-958",23,2022,51,"A Aimo, G Vergaro, A González, A Barison, J Lupón, V Delgado, ...", Stefan D Anker
Stefan D. Anker,"Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.","Heart Failure Monitor 4 (1), 2-6",24,2003,3,"M Crosato, W Steinborn, SD Anker", Stefan D Anker
Stefan D. Anker,Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure,"International journal of cardiology 147 (1), 47-51",20,2011,9,"T Szabo, S von Haehling, D Habedank, M Rauchhaus, M Lainscak, ...", Stefan D Anker
Stefan D. Anker,Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR‐Preserved trial,"European journal of heart failure 25 (8), 1337-1348",19,2023,12,"A Sharma, JP Ferreira, F Zannad, SJ Pocock, G Filippatos, E Pfarr, ...", Stefan D Anker
Stefan D. Anker,A tissue‐specific screen of ceramide expression in aged mice identifies ceramide synthase‐1 and ceramide synthase‐5 as potential regulators of fiber size and strength in …,"Aging Cell 19 (1), e13049",19,2020,13,"B Tosetti, S Brodesser, A Brunn, M Deckert, M Blüher, W Doehner, ...", Stefan D Anker
Stefan D. Anker,"23 Heart Failure: Epidemiology, Pathophysiology and Diagnosis",,19,2006,4,"J McMurray, M Komajda, S Anker, R Gardner", Stefan Anker
Stefan D. Anker,"Growth hormone secretagogues: history, mechanism of action, and clinical development","JCSM Rapid Communications 3 (1), 25-37",18,2020,6,"J Ishida, M Saitoh, N Ebner, J Springer, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,Functional and symptomatic clinical trial endpoints: the HFC-ARC scientific expert panel,"Heart Failure 10 (12), 889-901",18,2022,24,"MA Psotka, WT Abraham, M Fiuzat, G Filippatos, JA Lindenfeld, T Ahmad, ...", Stefan D Anker
Stefan D. Anker,Furosemide induces mortality in a rat model of chronic heart failure,"International journal of cardiology 160 (1), 20-25",18,2012,12,"H Rokutan, C Suckow, S von Haehling, S Strassburg, B Bockmeyer, ...", Stefan D Anker
Stefan D. Anker,Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post‐hoc analysis of the ATHENA trial,"European journal of heart failure 24 (6), 1094-1101",17,2022,11,"M Vaduganathan, JP Piccini, AJ Camm, HJGM Crijns, SD Anker, J Butler, ...", Stefan D Anker
Stefan D. Anker,Cardiorenal syndromes–recommendations from clinical practice guidelines: the cardiologist's view,"Cardiorenal Syndromes in Critical Care 165, 145-152",15,2010,3,"P Ponikowski, C Ronco, SD Anker", Stefan D Anker
Stefan D. Anker,"Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: An analysis from the ESC …","European Journal of Heart Failure 25 (7), 1061-1071",14,2023,23,"M Adamo, O Chioncel, L Benson, B Shahim, MG Crespo‐Leiro, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure,"Hormone and metabolic research 37 (02), 106-110",15,2005,3,"W Doehner, SD Anker, IF Godsland", SD Anker
Stefan D. Anker,Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study,"Archives of Medical Science 9 (2), 261-267",15,2013,12,"S von Haehling, M Lainscak, T Kung, L Cramer, S Fülster, U Pelzer, ...", Stefan D Anker
Stefan D. Anker,Association of deranged adrenal steroid metabolism with anemia in chronic heart failure,"The American journal of cardiology 96 (1), 101-103",15,2005,9,"DO Okonko, M Crosato, PR Kalra, M Cicoira, M John, W Doehner, ...", Stefan D Anker
Stefan D. Anker,The role of micronutrients and macronutrients in patients hospitalized for heart failure,"Heart Failure Clinics 9 (3), 345-357",15,2013,3,"TD Trippel, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial,"Emergency Medicine Journal 30 (8), 633-637",15,2013,8,"M Möckel, J Searle, O Hartmann, SD Anker, WF Peacock, AHB Wu, ...", Stefan D Anker
Stefan D. Anker,Stroke in heart failure in sinus rhythm: the warfarin versus aspirin in reduced cardiac ejection fraction trial,"Cerebrovascular Diseases 36 (1), 74-78",15,2013,19,"PM Pullicino, JLP Thompson, RL Sacco, AR Sanford, M Qian, JR Teerlink, ...", Stefan D Anker
Stefan D. Anker,"Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention","Journal of Cachexia, Sarcopenia and Muscle 5, 171-176",15,2014,2,"SD Anker, S von Haehling",Stefan D Anker
Stefan D. Anker,Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial,"PloS one 9 (11), e113447",15,2014,21,"S Graham, S Ye, M Qian, AR Sanford, MR Di Tullio, RL Sacco, DL Mann, ...", Stefan D Anker
Stefan D. Anker,Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized …,"BMC neurology 16, 1-7",15,2016,10,"N Scherbakov, N Ebner, A Sandek, A Meisel, KG Haeusler, ...", Stefan D Anker
Stefan D. Anker,TRUE-AHF Investigators and Committees. Rationale for and design of the TRUE-AHF trial: the effects of ularitide on the short-term clinical course and long-term mortality of …,"Eur J Heart Fail 19 (5), 673-681",15,2017,16,"M Packer, R Holcomb, WT Abraham, S Anker, K Dickstein, G Filippatos, ...", S Anker
Stefan D. Anker,Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis,"ESC Heart Failure 7 (5), 2838-2852",15,2020,13,"C Tschöpe, S Van Linthout, S Jäger, R Arndt, T Trippel, I Müller, ...", Stefan D Anker
Stefan D. Anker,The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure,"Journal of Cachexia, Sarcopenia and Muscle 12 (3), 555-567",15,2021,17,"P Pandhi, KW Streng, SD Anker, JG Cleland, K Damman, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Association between up‐titration of medical therapy and total hospitalizations and mortality in patients with recent worsening heart failure across the ejection fraction spectrum,"European journal of heart failure 23 (7), 1170-1181",15,2021,15,"V Bistola, P Simitsis, J Parissis, W Ouwerkerk, DJ van Veldhuisen, ...", Stefan D Anker
Stefan D. Anker,Outcomes with finerenone in participants with stage 4 CKD and type 2 diabetes: a FIDELITY subgroup analysis,"Clinical Journal of the American Society of Nephrology 18 (5), 602-612",15,2023,17,"P Sarafidis, R Agarwal, B Pitt, C Wanner, G Filippatos, J Boletis, KR Tuttle, ...", Stefan D Anker
Stefan D. Anker,C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure,"Clinical science 118 (1), 71-77",16,2010,6,"PR Kalra, JR Clague, AJ Coats, SD Anker, PA Poole-Wilson, AD Struthers", Stefan D Anker
Stefan D. Anker,Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry,"European Journal of Preventive Cardiology 30 (13), 1346-1358",15,2023,20,"O Chioncel, L Benson, MG Crespo-Leiro, SD Anker, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,Heart failure is a risk factor for incident driving cessation among community-dwelling older adults: Findings from a prospective population study,"Journal of Cardiac Failure 17 (12), 1035-1040",16,2011,10,"RV Sims, M Mujib, G McGwin Jr, Y Zhang, MI Ahmed, RV Desai, IB Aban, ...", Stefan D Anker
Stefan D. Anker,Method of Treating Cachexia and Sarcopenia,"US Patent App. 14/101,272",16,2014,3,"A Coats, J Beadle, S Anker", Stefan Anker
Stefan D. Anker,Relationship between stage of kidney disease and incident heart failure in older adults,"American Journal of Nephrology 34 (2), 135-141",16,2011,12,"CB Bowling, MA Feller, M Mujib, PP Pawar, Y Zhang, OJ Ekundayo, ...", Stefan D Anker
Stefan D. Anker,Does obesity make it better or worse: insights into cardiovascular illnesses,"European heart journal 34 (5), 330-332",16,2013,3,"S von Haehling, O Hartmann, SD Anker", Stefan D Anker
Stefan D. Anker,HFA of the ESC position paper on the management of LVAD‐supported patients for the non‐LVAD specialist healthcare provider Part 3: at the hospital and discharge,"ESC Heart Failure 8 (6), 4425-4443",14,2021,41,"F Gustafsson, B Ben Avraham, O Chioncel, T Hasin, A Grupper, A Shaul, ...", Stefan Anker
Stefan D. Anker,Distinct pathophysiological pathways in women and men with heart failure,"European journal of heart failure 24 (9), 1532-1544",14,2022,16,"A Ravera, BT Santema, RA de Boer, SD Anker, NJ Samani, CC Lang, ...", Stefan D Anker
Stefan D. Anker,Side effects and treatment initiation barriers of sodium–glucose cotransporter 2 inhibitors in heart failure: a systematic review and meta‐analysis,"European journal of heart failure 24 (9), 1625-1632",14,2022,8,"D Vukadinović, A Abdin, SD Anker, GMC Rosano, F Mahfoud, M Packer, ...", Stefan D Anker
Stefan D. Anker,Evaluating the application of chronic heart failure therapies and developing treatments in individuals with recent myocardial infarction: a review,"JAMA cardiology 7 (10), 1067-1075",14,2022,8,"J Harrington, MC Petrie, SD Anker, DL Bhatt, WS Jones, JA Udell, ...", Stefan D Anker
Stefan D. Anker,The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients …,"Diabetes, Obesity and Metabolism 24 (4), 662-674",14,2022,7,"K Kaku, C Wanner, SD Anker, S Pocock, A Yasui, M Mattheus, SS Lund", Stefan D Anker
Stefan D. Anker,Abnormal serum calcium levels are associated with clinical response to maximization of heart failure therapy,"Pol Arch Med Wewn 125 (1-2), 54-64",16,2015,11,"P Rozentryt, JT Niedziela, B Hudzik, W Doehner, EA Jankowska, J Nowak, ...", Stefan D Anker
Stefan D. Anker,Efficacy of empagliflozin in patients with heart failure across kidney risk categories,"Journal of the American College of Cardiology 81 (19), 1902-1914",14,2023,15,"J Butler, M Packer, TJ Siddiqi, M Böhm, M Brueckmann, JL Januzzi, ...", Stefan D Anker
Stefan D. Anker,"Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas","ESC Heart Failure 9 (6), 3713-3736",14,2022,21,"A Palazzuoli, M Metra, SP Collins, M Adamo, AP Ambrosy, LE Antohi, ...", Stefan Anker
Stefan D. Anker,Emphasis on abdominal obesity as a modifier of eplerenone effect in heart failure: hypothesis-generating signals from EMPHASIS-HF,"European journal of heart failure 19 (9), 1198",14,2017,4,"A Ahmed, MR Blackman, M White, SD Anker", Stefan D Anker
Stefan D. Anker,"Body mass, chronic heart failure, surgery and survival","The Journal of Heart and Lung Transplantation 29 (3), 261-264",14,2010,2,"AL Clark, SD Anker", Stefan D Anker
Stefan D. Anker,Vitamin D in chronic kidney disease: more questions than answers,"JAMA 307 (7), 722-723",14,2012,2,"SD Anker, S von Haehling",Stefan D Anker
Stefan D. Anker,"The effects of bilateral lung transplantation on ventilatory efficiency, oxygen uptake and the right heart: a two‐yr follow‐up","Clinical transplantation 25 (1), E38-E45",14,2011,9,"D Habedank, R Ewert, M Hummel, M Dandel, F Habedank, C Knosalla, ...", Stefan D Anker
Stefan D. Anker,The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM‐CHF randomized controlled trial,"ESC Heart Failure 7 (6), 3310-3319",14,2020,11,"M Schulz, N Griese‐Mammen, PM Schumacher, SD Anker, F Koehler, ...", Stefan D Anker
Stefan D. Anker,Group CT; CANTOS Trial Group,Antiinflammatory therapy with canakinumab for atherosclerotic disease. N …,14,2017,28,"PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...", SD Anker
Stefan D. Anker,"Assessment of baroreflex sensitivity has no prognostic value in contemporary, optimally managed patients with mild‐to‐moderate heart failure with reduced ejection fraction: a …","European Journal of Heart Failure 21 (1), 50-58",14,2019,12,"B Paleczny, M Olesińska‐Mader, A Siennicka, P Niewiński, K Nowak, ...", Stefan D Anker
Stefan D. Anker,Heart failure hospitalization in adults receiving hemodialysis and the effect of intravenous iron therapy,"Heart Failure 9 (7), 518-527",14,2021,16,"PS Jhund, MC Petrie, M Robertson, PB Mark, MR MacDonald, E Connolly, ...", Stefan D Anker
Stefan D. Anker,Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency,"European Journal of Heart Failure 24 (5), 833-842",9,2022,16,"SD Anker, P Ponikowski, MS Khan, T Friede, EA Jankowska, V Fabien, ...",Stefan D Anker
Stefan D. Anker,"Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease","European Heart Journal-Cardiovascular Pharmacotherapy 9 (1), 85-93",9,2023,16,"G Filippatos, SD Anker, B Pitt, DK McGuire, P Rossing, LM Ruilope, ...", Stefan D Anker
Stefan D. Anker,"Acute heart failure and valvular heart disease: a scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European …","European Journal of Heart Failure 25 (7), 1025-1048",9,2023,49,"O Chioncel, M Adamo, M Nikolaou, J Parissis, A Mebazaa, MB Yilmaz, ...", Stefan D Anker
Stefan D. Anker,Endotoxin and severity of chronic heart failure,"JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37 (2), 190A-190A",10,2001,9,"M Rauchhaus, W Doehner, A Bolger, R Sharma, H Schmidt, C Davos, ...", SD Anker
Stefan D. Anker,"Serum total cholesterol, high-density lipoprotein, and prognosis in patients with chronic heart failure","JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37 (2), 156A-156A",10,2001,9,"M Rauchhaus, W Doehner, CH Davos, R Sharma, A Bolger, H Gabriel, ...", SD Anker
Stefan D. Anker,Frailty and heart failure: State‐of‐the‐art review,"Journal of Cachexia, Sarcopenia and Muscle 14 (5), 1959-1972",9,2023,6,"KM Talha, A Pandey, M Fudim, J Butler, SD Anker, MS Khan", Stefan D Anker
Stefan D. Anker,Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance,"Heart 86 (2), 139-144",10,2001,7,"W Shamim, M Yousufuddin, DP Francis, P Gualdiero, JW Honour, ...", SD Anker
Stefan D. Anker,The significance of 123I-BMIPP delayed scintigraphic imaging in cardiac patients,"International journal of cardiology 117 (2), 145-151",10,2007,8,"YJ Akashi, K Kida, K Suzuki, K Inoue, K Kawasaki, M Yamauchi, H Musha, ...", Stefan D Anker
Stefan D. Anker,Muscle metabolism and exercise capacity in cachexia,"Current pharmaceutical design 17 (35), 3838-3845",10,2011,3,"V Adams, S D Anker, G Schuler", Stefan D Anker
Stefan D. Anker,Anaemia predicts health related quality of life in heart failure patients,"International journal of cardiology 162 (2), 67-68",10,2013,3,"W Doehner, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy,"International journal of cardiology 177 (1), 248-254",10,2014,16,"P Rozentryt, J Nowak, J Niedziela, B Hudzik, W Doehner, EA Jankowska, ...", Stefan D Anker
Stefan D. Anker,Effect of exogenous intravenous administrations of GLP-1 and/or GIP on circulating pro-atrial natriuretic peptide in subjects with different stages of glucose tolerance.,Diabetes care 38 (1),10,2015,10,"N Rudovich, O Pivovarova, Ö Gögebakan, A Sparwasser, W Doehner, ...", Stefan D Anker
Stefan D. Anker,Role of hyperkalemia in heart failure and the therapeutic use of potassium binders,"Heart Failure, 537-560",10,2017,4,"CMS Sarwar, AA Bhagat, SD Anker, J Butler", Stefan D Anker
Stefan D. Anker,Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia,"International journal of cardiology 218, 312-317",10,2016,10,"M Saitoh, M Hatanaka, M Konishi, J Ishida, S Palus, N Ebner, W Döhner, ...", Stefan D Anker
Stefan D. Anker,Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial,"ESC heart failure 6 (2), 297-307",10,2019,24,"TC Lee, M Qian, L Mu, MR Di Tullio, S Graham, DL Mann, K Nakanishi, ...", Stefan D Anker
Stefan D. Anker,Circulating plasma concentrations of ACE2 in men and women with heart failure and effects of renin-angiotensin-aldosterone-inhibitors,"European Heart Journal 41 (19), 1810-1817",10,2020,18,"IE Sama, A Ravera, BT Santema, H van Goor, JM ter Maaten, ...", Stefan D Anker
Stefan D. Anker,HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non‐hospital settings …,"ESC Heart Failure 8 (6), 4394-4408",10,2021,41,"B Ben Avraham, MG Crespo‐Leiro, G Filippatos, I Gotsman, P Seferovic, ...", Stefan Anker
Stefan D. Anker,Kidney function assessment and endpoint ascertainment in clinical trials,"European Heart Journal 43 (14), 1379-1400",10,2022,10,"MS Khan, GL Bakris, M Packer, I Shahid, SD Anker, GC Fonarow, ...", Stefan D Anker
Stefan D. Anker,Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure,"European Journal of Heart Failure 24 (6), 1009-1019",10,2022,21,"M Nath, SPR Romaine, A Koekemoer, S Hamby, TR Webb, CP Nelson, ...", Stefan D Anker
Stefan D. Anker,SGLT2 inhibitors: from antihyperglycemic agents to all-around heart failure therapy,"Circulation 146 (4), 299-302",10,2022,3,"SD Anker, MS Usman, J Butler",Stefan D Anker
Stefan D. Anker,Clinical implications of low estimated protein intake in patients with heart failure,"Journal of Cachexia, Sarcopenia and Muscle 13 (3), 1762-1770",10,2022,16,"KW Streng, HL Hillege, JM Ter Maaten, DJ van Veldhuisen, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure,"European Journal of Heart Failure 24 (2), 308-320",9,2022,12,"D Ceelen, AA Voors, J Tromp, DJ van Veldhuisen, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Beta blockers and glucose metabolism in chronic heart failure: friend or foe?,Clinical Research in Cardiology: Official Journal of the German Cardiac …,8,2008,2,"W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,"The relationship between high-density lipoprotein, bacterial lipopolysaccharide, and tumour necrosis factor-α in patients with acute decompensated heart failure","Archives of Medical Science 4 (4), 380-385",8,2008,7,"AV Zimmermann, W Doehner, AV Pérez, H Schmidt, HD Volk, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Medizinische Forschungsbedingungen in Deutschland-Eine Aufforderung auszuwandern,"Deutsches Arzteblatt-Arztliche Mitteilungen-Ausgabe A 100 (28-29), 1916-1919",8,2003,4,"M Tschop, W Arlt, SD Anker, M Ristovv", Stefan D Anker
Stefan D. Anker,Noninvasive Home Telemonitoring: The Trans-European Network–Home-Care Management System,"Journal of the American College of Cardiology 48 (4), 850-851",8,2006,2,"F Koehler, SD Anker", Stefan D Anker
Stefan D. Anker,Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure,"ESC heart failure 7 (3), 953-963",10,2020,18,"M Kobayashi, S Stienen, JM Ter Maaten, K Dickstein, NJ Samani, ...", Stefan D Anker
Stefan D. Anker,Markers of intestinal ischemia relate to immune activation in chronic heart failure,"Circulation 100 (18), 206-207",8,1999,10,"V Koloczek, M Rauchhaus, R Crane, I Bjarnanson, IS Menzies, M Kemp, ...", SD Anker
Stefan D. Anker,Ten lessons from the EMPEROR‐Reduced trial,"European Journal of Heart Failure 22 (11), 1991-1993",8,2020,5,"J Butler, F Zannad, G Filippatos, SD Anker, M Packer", Stefan D Anker
Stefan D. Anker,Ghrelin. Mol Metab 4: 437–460,,8,2015,57,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,Ghrelin. Mol Metab. 2015; 4 (6): 437-60,PMC4443295 6 (7),8,,6,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,Leveraging electronic health records to streamline the conduct of cardiovascular clinical trials,"European heart journal 44 (21), 1890-1909",7,2023,18,"MS Khan, MS Usman, KM Talha, HGC Van Spall, SJ Greene, ...", Stefan D Anker
Stefan D. Anker,"Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An …","European Journal of Heart Failure 25 (7), 1049-1060",7,2023,25,"B Shahim, A Shahim, M Adamo, O Chioncel, L Benson, MG Crespo‐Leiro, ...", Stefan D Anker
Stefan D. Anker,Minimal clinically important differences in 6-minute walk test in patients with HFrEF and iron deficiency,"Journal of Cardiac Failure 29 (5), 760-770",7,2023,16,"MS Khan, SD Anker, T Friede, EA Jankowska, M Metra, IL Piña, AJ Coats, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease,"Diabetes Research and Clinical Practice 186, 109837",7,2022,11,"SD Anker, LE Sander, DH Fitchett, B Zinman, AP Ofstad, C Wanner, ...",Stefan D Anker
Stefan D. Anker,Telomere length is independently associated with all-cause mortality in chronic heart failure,"Heart 108 (2), 124-129",7,2022,21,"SPR Romaine, M Denniff, V Codd, M Nath, A Koekemoer, SD Anker, ...", Stefan D Anker
Stefan D. Anker,New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial,"Clinical Research in Cardiology 111 (1), 50-59",7,2022,10,"JP Ferreira, JG Cleland, CSP Lam, SD Anker, MR Mehra, ...", Stefan D Anker
Stefan D. Anker,842-2 Hemoglobin level is associated with mortality and hospitalization in patients with severe chronic heart failure: Results from the COPERNICUS study,"Journal of the American College of Cardiology 43 (5S1), A216-A216",7,2004,9,"SD Anker, AJS Coats, EB Roecker, P Mohacsi, J Rouleau, H Krum, ...",Stefan D Anker
Stefan D. Anker,Health status across major subgroups of patients with heart failure and preserved ejection fraction,"European journal of heart failure 25 (9), 1623-1631",6,2023,19,"TJ Siddiqi, SD Anker, G Filippatos, JP Ferreira, SJ Pocock, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure,"Circulation 148 (13), 1011-1022",6,2023,10,"M Packer, J Butler, C Zeller, SJ Pocock, M Brueckmann, JP Ferreira, ...", Stefan D Anker
Stefan D. Anker,Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure,"Journal of the American College of Cardiology 82 (20), 1921-1931",6,2023,30,"W Ouwerkerk, JP Belo Pereira, T Maasland, JE Emmens, SM Figarska, ...", Stefan Anker
Stefan D. Anker,Growth hormone resistance in chronic heart failure,"Journal of the American College of Cardiology 31 (2SA), 204A-204A",7,1998,6,"SD Anker, M Volterrani, CD Pflaum, PA Poole-Wilson, CJ Strasburger, ...",SD Anker
Stefan D. Anker,B-type natriuretic peptide serum levels in acute heart failure,"European heart journal 25 (12), 1085-1085",7,2004,3,"GS Filippatos, SD Anker, F Kardaras", Stefan D Anker
Stefan D. Anker,Anemia in chronic heart failure-clinical and prognostic significance,"Current Medicinal Chemistry-Cardiovascular & Hematological Agents 3 (4), 297-303",7,2005,3,"T Karhausen, SD Anker, W Doehner", Stefan D Anker
Stefan D. Anker,"Elevated plasma xanthine oxidase activity in chronic heart failure: Source of increased oxygen radical load and effect of allopurinol in a placebo controlled, double blinded …","Journal of the American College of Cardiology 41 (6S1), 207-207",7,2003,8,"W Doehner, MM Tarpey, DV Pavitt, AP Bolger, R Wensel, S von Haehling, ...", Stefan D Anker
Stefan D. Anker,"The effects of enteral supplementation in patients with cardiac cachexia–a prospective, randomised, double-blind, placebo controlled trial","3rd cachexia conference abstract book, Rome, Italy, 82",7,2005,6,"P Rozentryt, A Michalak, JU Nowak, A Brachowska, L Polonski, SD Anker", SD Anker
Stefan D. Anker,Statins for heart failure: where to go from here?,"Archives of Medical Science Special Issues 2007 (4), 141-141",7,2007,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular …","Eur Heart J 28 (1), 98-136",7,2007,7,"L Rydén, PJ Grant, SD Anker, C Berne, F Cosentino, N Danchin, ...", Stefan D Anker
Stefan D. Anker,The roles of immunity and autoimmunity in chronic heart failure,"Chronic Viral and Inflammatory Cardiomyopathy, 155-168",7,2006,3,"S Von Haehling, W Doehner, SD Anker", SD Anker
Stefan D. Anker,Alterations in nutrition and body mass in heart failure,"Heart Failure: A Companion to Braunwald's Heart Disease, 330-345",7,2011,3,"W Doehner, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure,"Circulation 123, 1873-1880",7,2011,13,"K Friedrich, W Sebastian, S Michael, S Udo, S Karl, B Michael, B Herbert, ...", D Anker Stefan
Stefan D. Anker,Iron deficiency and anaemia in heart failure,UNI-MED Verlag,7,2012,2,"SD Anker, S von Haehling",Stefan D Anker
Stefan D. Anker,"Late‐onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long‐term survival","ESC Heart Failure 1 (1), 41-51",7,2014,9,"EA Jankowska, M Tkaczyszyn, K Węgrzynowska‐Teodorczyk, J Majda, ...", Stefan D Anker
Stefan D. Anker,ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [Internet]. Vol. 37,European Heart Journal. Oxford University Press,7,2016,6,"P Ponikowski, AA Voors, SD Anker, H Bueno, JGF Cleland, AJS Coats", SD Anker
Stefan D. Anker,Eisenmangel bei Patienten mit chronischer Herzinsuffizienz–diagnostische Algorithmen und therapeutische Optionen anhand der aktuellen Studienlage,"DMW-Deutsche Medizinische Wochenschrift 142 (10), 752-757",7,2017,12,"W Doehner, S Blankenberg, E Erdmann, G Ertl, G Hasenfuß, ...", Stefan D Anker
Stefan D. Anker,Ghrelin Mol Metab. 2015; 4: 437–60,Impact of somatotrope axis upon immune system,7,2015,6,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,Ghrelin. Mol Metab 4 (6): 437–460,,7,2015,57,"TD Muller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,Digoxin and 30-day all-cause readmission in long-term care residents hospitalized for heart failure,"Journal of the American Medical Directors Association 18 (9), 761-765",7,2017,16,"HM Sheriff, MR Thogaripally, G Panjrath, C Arundel, Q Zeng, GC Fonarow, ...", Stefan D Anker
Stefan D. Anker,Aspirin does not increase heart failure events in heart failure patients: from the WARCEF trial,"JACC: Heart Failure 5 (8), 603-610",6,2017,19,"JR Teerlink, M Qian, NA Bello, RS Freudenberger, B Levin, MR Di Tullio, ...", Stefan D Anker
Stefan D. Anker,Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls,"Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1961-1966",6,2020,10,"A Shafieesabet, N Scherbakov, N Ebner, A Sandek, S Lokau, ...", Stefan D Anker
Stefan D. Anker,"Preserved skeletal muscle mitochondrial function, redox state, inflammation and mass in obese mice with chronic heart failure","Nutrients 12 (11), 3393",6,2020,11,"G Gortan Cappellari, A Aleksova, M Dal Ferro, A Cannatà, A Semolic, ...", Stefan D Anker
Stefan D. Anker,Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine …,"Diabetes, Obesity and Metabolism 25 (3), 894-898",5,2023,13,"P Rossing, JG Garweg, SD Anker, T Osonoi, B Pitt, SE Rosas, LM Ruilope, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in Heart Failure with a Preserved Ejection Fraction. Reply.,"The New England Journal of Medicine 386 (21), e57-e57",5,2022,3,"SD Anker, J Butler, M Packer",Stefan D Anker
Stefan D. Anker,Impact of empagliflozin in heart failure with reduced ejection fraction in patients with ischemic versus nonischemic cause,"Journal of the American Heart Association 12 (1), e027652",5,2023,16,"MS Khan, J Butler, SD Anker, G Filippatos, JP Ferreira, SJ Pocock, ...", Stefan D Anker
Stefan D. Anker,Less loop diuretic use in patients on sacubitril/valsartan undergoing remote pulmonary artery pressure monitoring,"ESC heart failure 9 (1), 155-163",5,2022,18,"M Böhm, B Assmus, SD Anker, FW Asselbergs, J Brachmann, ME Brett, ...", Stefan D Anker
Stefan D. Anker,Extra‐cardiac targets in the management of cardiometabolic disease: Device‐based therapies,"ESC Heart Failure 8 (4), 3327-3338",5,2021,10,"A Jorbenadze, M Fudim, F Mahfoud, PB Adamson, T Bekfani, R Wachter, ...", Stefan D Anker
Stefan D. Anker,Therapeutic patents for chronic heart failure: a review of patent applications from 1996 to 2002,"Expert Opinion on Therapeutic Patents 14 (5), 639-654",5,2004,3,"SD Anker, EA Jankowska, DO Okonko",Stefan D Anker
Stefan D. Anker,"Insuficiencia cardiaca: epidemiología, fisiopatología y diagnóstico","Tratado de medicina cardiovascular de la ESC, 739-776",5,2008,4,"J McMurray, M Komajda, S Anker, R Gardner", Stefan Anker
Stefan D. Anker,Experimental cancer cachexia severely impairs heart function,"Journal of Cardiac Failure 6 (14), S18",5,2008,4,"J Springer, S Palus, M Rauchhaus, SD Anker", Stefan D Anker
Stefan D. Anker,Cardiovascular safety reporting in contemporary breast cancer clinical trials,"Journal of the American Heart Association 11 (15), e025206",4,2022,12,"A Hamid, MS Anker, JC Ruckdeschel, MS Khan, A Tharwani, ...", Markus S Anker
Stefan D. Anker,Handgrip strength to screen early-onset sarcopenia in heart failure,"Clinical Nutrition ESPEN 50, 183-190",4,2022,16,"M Blanquet, G Massoulié, Y Boirie, C Guiguet-Auclair, A Mulliez, S Anker, ...", Stefan Anker
Stefan D. Anker,Heart failure with normal LVEF in BIOSTAT-CHF,"International Journal of Cardiology 364, 85-90",4,2022,16,"L Baumhove, J Tromp, S Figarska, BJ van Essen, SD Anker, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol,"Clinical and experimental emergency medicine 9 (2), 140",4,2022,22,"WF Peacock, AS Maisel, C Mueller, SD Anker, FS Apple, RH Christenson, ...", Stefan D Anker
Stefan D. Anker,Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome,"European Journal of Heart Failure 25 (2), 163-173",4,2023,14,"CCS van der Hoef, EM Boorsma, JE Emmens, BJ van Essen, M Metra, ...", Stefan D Anker
Stefan D. Anker,Biomarker changes as surrogate endpoints in early‐phase trials in heart failure with reduced ejection fraction,"ESC heart failure 9 (4), 2107-2118",4,2022,17,"G Savarese, A Uijl, W Ouwerkerk, J Tromp, SD Anker, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Medication-attributable adverse events in heart failure trials,"Heart Failure 11 (4), 425-436",4,2023,10,"J Harrington, GC Fonarow, MS Khan, A Hernandez, S Anker, M Böhm, ...", Stefan Anker
Stefan D. Anker,"Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at …","Diabetes, Obesity and Metabolism 25 (6), 1512-1522",4,2023,16,"JB McGill, R Agarwal, SD Anker, GL Bakris, G Filippatos, B Pitt, ...", Stefan D Anker
Stefan D. Anker,Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP …,"European Heart Journal 44 (17), 1526-1529",4,2023,19,"CJ Kapelios, L Benson, MG Crespo-Leiro, SD Anker, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,"Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR‐Preserved trial","European Journal of Heart Failure 25 (8), 1375-1383",4,2023,16,"M Böhm, J Butler, M Krawczyk, F Mahfoud, B Haring, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Ferric carboxymaltose in iron-deficient patients with hospitalized heart failure and reduced kidney function,"Clinical Journal of the American Society of Nephrology 18 (9), 1124-1134",4,2023,16,"IC Macdougall, P Ponikowski, AG Stack, DC Wheeler, SD Anker, J Butler, ...", Stefan D Anker
Stefan D. Anker,The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: post hoc analysis of the …,"Diabetes, Obesity and Metabolism 25 (10), 2989-2998",4,2023,15,"P Rossing, SD Anker, G Filippatos, B Pitt, LM Ruilope, LK Billings, ...", Stefan D Anker
Stefan D. Anker,Metabolic dysfunction associated steatotic liver disease and the heart,"Hepatology, 10.1097",4,2023,7,"S Driessen, SM Francque, SD Anker, MC Cabezas, DE Grobbee, ...", Stefan D Anker
Stefan D. Anker,Ghrelin Mol Metab 2015; 4: 437–460,DOI,5,,10,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program,"European Journal of Heart Failure 26 (1), 155-164",4,2024,13,"JP Ferreira, M Packer, J Butler, G Filippatos, SJ Pocock, JL Januzzi, ...", Stefan D Anker
Stefan D. Anker,Acute peripheral edema in patients with chronic heart failure is associated with endotoxemia and immune activation,"Journal of the American College of Cardiology 31, 155-155",5,1998,7,"J Niebauer, M Kemp, M Dominguez, M Rauchhaus, P Poole-Wilson, ...", S Anker
Stefan D. Anker,ESC-HFA HF Long-Term Registry investigators,hospital and 1,5,,16,"G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ...", S Anker
Stefan D. Anker,Growth hormone treatment in chronic heart failure: lessons from the first 99 patients,"European heart journal 19 (11), 1605-1607",5,1998,3,"M Cicoira, AJ Coats, SD Anker", SD Anker
Stefan D. Anker,Insulin-like growth factor-I can be helpful towards end of life,"BMJ 322 (7287), 674",5,2001,3,"A Bolger, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Tumor-Nekrose-Faktor alpha bei chronischer Herzinsuffizienz Klinische Manifestation und therapeutische Möglichkeiten: Klinische Manifestation und therapeutische Möglichkeiten,"Herz 26, 437-446",5,2001,3,"S Genth-Zotz, AP Bolger, SD Anker", Stefan D Anker
Stefan D. Anker,Kommentar zu den Leitlinien (2021) der ESC zur Diagnose und Behandlung akuter und chronischer Herzinsuffizienz,"Die Kardiologie 16 (3), 207-212",4,2022,11,"S Frantz, S Anker, J Bauersachs, M Böhm, J Boer, S Busch, N Frey, ...", Stefan Anker
Stefan D. Anker,Major depression and anxiety among patients hospitalized with heart failure,"American Journal of Cardiology 142, 153-155",4,2021,8,"J Sreenivasan, MS Khan, RK Ochani, J Bhinder, MS Usman, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Eisenmangel,"Der Internist 6 (58), 627-638",4,2017,3,"S von Haehling, H Ottenjann, SD Anker", SD Anker
Stefan D. Anker,"Effect of sodium zirconium cyclosilicate (ZS-9) on aldosterone from the phase 3 randomized, double-blind, placebo-controlled HARMONIZE study",Wiley-blackwell,4,2015,6,"F Zannad, HS Rasmussen, PT Lavin, A Yang, B Singh, SD Anker", Stefan-D Anker
Stefan D. Anker,Kidney function after initiation and discontinuation of empagliflozin in patients with heart failure with and without type 2 diabetes: insights from the EMPERIAL trials,"Circulation 144 (15), 1265-1267",4,2021,13,"SD Anker, P Ponikowski, C Wanner, E Pfarr, S Hauske, B Peil, A Salsali, ...",Stefan D Anker
Stefan D. Anker,Iron deficiency: Recognition and treatment,"Der Internist 58, 627-638",4,2017,3,"S von Haehling, H Ottenjann, SD Anker", Stefan-D Anker
Stefan D. Anker,Anaemia in Patients Hospitalized for Acute Heart Failure,"Journal of Cardiac Failure 6 (15), S105",4,2009,7,"S von Haehling, T Kung, L Hodoscek-Majc, JC Schefold, W Doehner, ...", Stefan D Anker
Stefan D. Anker,Anemia and congestive heart failure,"Circulation 108 (6), e41-e42",4,2003,3,"W Steinborn, P Ponikowski, S Anker", Stefan Anker
Stefan D. Anker,Empagliflozin in Heart Failure With a Preserved Ejection Fraction>= 50%-Results From the EMPEROR-Preserved Clinical Trial,"Circulation 144 (25), E571-E572",3,2021,1,SD Anker,Stefan D Anker
Stefan D. Anker,Effect of empagliflozin on total events of myocardial infarctions by subtype in the EMPA-REG OUTCOME trial,"Circulation 142 (Suppl_3), A14959-A14959",3,2020,14,"DH Fitchett, B Zinman, SE Inzucchi, C Wanner, SD Anker, S Pocock, ...", Stefan D Anker
Stefan D. Anker,"Management of patients with heart failure and secondary mitral regurgitation: a joint position statement from the Heart Failure Association (HFA), European Association of …",Eur Heart J,3,2020,41,"F Ruschitzka, SD Anker, A Baumbach, WT Abraham, O Alfieri, ...", SD Anker
Stefan D. Anker,Cardiac events associated with immune checkpoint inhibitor therapy: the devil is in the detail,"European Heart Journal 42 (16), 1637-1637",3,2021,3,"MS Anker, AJS Coats, SD Anker",Markus S Anker
Stefan D. Anker,"Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis (vol 7, pg 3298, 2020)","ESC HEART FAILURE 8 (3), 2362-2362",3,2021,9,"J Butler, MS Usman, MS Khan, SJ Greene, T Friede, M Vaduganathan, ...", SD Anker
Stefan D. Anker,Cardiovascular risk factors and complications in patients infected with COVID-19: a systematic review,Available at SSRN 3569855,3,2020,12,"J Sreenivasan, MS Khan, SD Anker, R Kaul, SU Khan, M Metra, M Senni, ...", Stefan D Anker
Stefan D. Anker,"Exercise for Frail, Elderly Patients with Acute Heart Failure—A Strong Step Forward","New England Journal of Medicine 385 (3), 276-277",3,2021,2,"SD Anker, AJS Coats",Stefan D Anker
Stefan D. Anker,Finerenone in patients with CKD and T2D with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial,,3,2022,9,"GS Filippatos, B Pitt, RL Agarwal, D Farmakis, LM Ruilope Urioste, ...",
Stefan D. Anker,Vorhofflimmerndiagnostik mittels EKG-fähiger Smartwatches,"Der Nervenarzt 93 (2), 175-178",3,2022,4,"W Haverkamp, O Göing, M Anker, SD Anker", Markus Anker
Stefan D. Anker,Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure,"ESC heart failure 9 (2), 885-893",3,2022,10,"MS Usman, MS Khan, GC Fonarow, SJ Greene, T Friede, ...", Stefan D Anker
Stefan D. Anker,"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis (vol 43, pg 474, 2022)","EUROPEAN HEART JOURNAL 43 (20), 1989-1989",3,2022,11,"R Agarwal, G Filippatos, B Pitt, SD Anker, P Rossing, A Joseph, P Kolkhof, ...", Stefan D Anker
Stefan D. Anker,The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia,"Journal of Cachexia, Sarcopenia and Muscle 13 (4), 2202-2210",3,2022,9,"S Palus, Y Elkina, T Braun, S von Haehling, W Döhner, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Bone status in men with heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure,"European Journal of Heart Failure 25 (5), 714-723",3,2023,11,"G Loncar, T Garfias‐Veitl, M Valentova, M Vatic, M Lainscak, D Obradović, ...", Stefan D Anker
Stefan D. Anker,Risk of urogenital infections in non-diabetic patients treated with sodium glucose transporter 2 (SGLT2) inhibitors. Systematic review and meta-analysis,Archivio Italiano di Urologia e Andrologia 95 (2),3,2023,17,"R Bapir, KH Bhatti, A Eliwa, HA García-Perdomo, N Gherabi, ...", Stefan D Anker
Stefan D. Anker,Recurrent Events in Cardiovascular Trials: ,"Journal of the American College of Cardiology 82 (14), 1445-1463",3,2023,8,"J Gregson, GW Stone, DL Bhatt, M Packer, SD Anker, C Zeller, B Redfors, ...", Stefan D Anker
Stefan D. Anker,Kidney function in cachexia and sarcopenia: Facts and numbers,"Journal of Cachexia, Sarcopenia and Muscle 14 (4), 1589-1595",3,2023,6,"M Okamura, M Konishi, J Butler, K Kalantar‐Zadeh, S von Haehling, ...", Stefan D Anker
Stefan D. Anker,Associations between baseline heart rate and blood pressure and time to events in heart failure with reduced ejection fraction patients: Data from the QUALIFY international …,"European Journal of Heart Failure 25 (11), 1985-1993",3,2023,10,"A Abdin, SD Anker, MR Cowie, GS Filippatos, P Ponikowski, L Tavazzi, ...", Stefan D Anker
Stefan D. Anker,Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps,"Journal of cachexia, sarcopenia and muscle 14 (6), 2779-2792",3,2023,9,"I Aprahamian, AJ Coats, JE Morley, T Klompenhouwer, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Efficacy and safety of empagliflozin according to background diuretic use in HFrEF: post-hoc analysis of EMPEROR-Reduced,"Heart Failure 12 (1), 35-46",3,2024,17,"NK Dhingra, S Verma, J Butler, SD Anker, JP Ferreira, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Urinary marker profiles in heart failure with reduced versus preserved ejection fraction,"Journal of cardiovascular translational research 17 (1), 3-12",3,2024,16,"KW Streng, HL Hillege, JM Ter Maaten, DJ van Veldhuisen, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,"The burden of frailty in heart failure: Prevalence, impacts on clinical outcomes and the role of heart failure medications","Journal of cachexia, sarcopenia and muscle",3,2024,8,"HY Lai, ST Huang, SD Anker, S von Haehling, M Akishita, H Arai, ...", Stefan D Anker
Stefan D. Anker,Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists,"Diabetologia 67 (2), 246-262",3,2024,5,"G Savarese, F Lindberg, G Filippatos, J Butler, SD Anker", Stefan D Anker
Stefan D. Anker,Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved,"Journal of Cachexia, Sarcopenia and Muscle 15 (1), 412-424",3,2024,16,"AJS Coats, J Butler, H Tsutsui, W Doehner, G Filippatos, JP Ferreira, ...", Stefan D Anker
Stefan D. Anker,Aldosterone and aldosterone synthase inhibitors in cardiorenal disease,American Journal of Physiology-Heart and Circulatory Physiology 326 (3 …,3,2024,12,"S Verma, A Pandey, AK Pandey, J Butler, JS Lee, H Teoh, CD Mazer, ...", Stefan D Anker
Stefan D. Anker,Interatrial shunt therapy in advanced heart failure: Outcomes from the open‐label cohort of the RELIEVE‐HF trial,European Journal of Heart Failure,3,2024,18,"J Rodés‐Cabau, JA Lindenfeld, WT Abraham, MR Zile, S Kar, ...", Stefan Anker
Stefan D. Anker,Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial,Circulation,3,2024,42,"AF Hernandez, JA Udell, WS Jones, SD Anker, MC Petrie, J Harrington, ...", Stefan D Anker
Stefan D. Anker,Evaluation of obese chronic heart failure patients with lean tissue adjusted peak oxygen consumption.,"Circulation 102 (18), 758-758",4,2000,4,"CH Davos, W Doehner, M Rauchhaus, SD Anker", SD Anker
Stefan D. Anker,Impact of levosimendan treatment on chronic heart failure,"American Journal of Cardiology 94 (8), 1105",4,2004,3,"S von Haehling, GP Diller, SD Anker", Stefan D Anker
Stefan D. Anker,"Body mass index, obesity, and cachexia vs survival in chronic heart failure: results from the ELITE 2 study","JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 37 (2), 203A-203A",4,2001,8,"SD Anker, CH Davos, D Francis, R Segal, E Santoro, PA Poole-Wilson, ...",SD Anker
Stefan D. Anker,Obesity and the Heart,"Journal of the American College of Cardiology 47 (11), 2274-2276",4,2006,3,"S Haehling, W Doehner, S Anker", S Anker
Stefan D. Anker,Statins: much more than cholesterol reduction,Archives of Medical Science Special Issues 2007 (4),4,2008,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Chronische Herzinsuffizienz-eine metabolische Erkrankung: Von der Pathophysiologie zu neuen Therapieansätzen,"Kardiologie up2date 1 (01), 45-56",4,2005,3,"W Döhner, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Chronotropic incompetence in adult patients with systemic right ventricle and univentricular circulation,"JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 45 (3), 325A-325A",4,2005,5,"GP Diller, DO Okonko, S von Haehling, S Anker, MA Gatzoulis", S Anker
Stefan D. Anker,Cancer cachexia therapy: a matter of helping the heart?,"Journal of Cardiac Failure 16 (8), S12",4,2010,6,"J Springer, A Tschirner, A Grzesiak, E Kaschina, S von Haehling, ...", Stefan D Anker
Stefan D. Anker,The impact of intravenous ferric carboxymaltose on renal function: an analysis of the FAIR-HF study,"Circulation 122 (suppl_21), A17341-A17341",4,2010,11,"P Ponikowski, I Macdougall, J Comin Colet, K Dickstein, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Exercise training in heart failure: from theory to practice,A consensus document of the Heart Failure Association and the European …,4,2011,3,"F Massimo, C Viviane, C Ugo",
Stefan D. Anker,The 6th Cachexia Conference: an introduction to clinical and basic research in an exiting area,"Journal of cachexia, sarcopenia and muscle 2, 189-190",4,2011,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Liver metabolism in cardiac cachexia,"International Journal of Cardiology 162 (2), 71-72",4,2013,3,"J Springer, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease,"International Journal of Cardiology 161 (3), 156-159",4,2012,9,"R Marčun, A Šustić, PM Brguljan, S Kadivec, J Farkaš, M Kosnik, ...", Stefan D Anker
Stefan D. Anker,Ferric carboxymaltose in iron deficient heart failure patients: a meta-analysis on individual patient data,Oxford Univ Press,4,2015,10,"SD Anker, J Comin-Colet, GS Filippatos, F Ruschitzka, GP Arutyunov, ...",Stefan-D Anker
Stefan D. Anker,Vitamin D Therapy and Cardiac Function in Chronic Kidney Disease—Reply,"JAMA 307 (21), 2253-2253",4,2012,3,"R Thadhani, H Tamez, SD Solomon",
Stefan D. Anker,Discharge initiation of ace inhibitors or arbs is associated with significantly lower 30-day all-cause readmission in hospitalized older patients with heart failure and reduced …,"Journal of the American College of Cardiology 63 (12S), A562-A562",4,2014,16,"K Sanam, V Bhatia, S Parvataneni, C Morgan, S Lloyd, F Hage, S Prabhu, ...", Stefan Anker
Stefan D. Anker,"Moving on up: the Journal of Cachexia, Sarcopenia and Muscle",Wiley-blackwell,4,2015,2,"S von Haehling, SD Anker", Stefan-D Anker
Stefan D. Anker,Vasodilation and exercise capacity in patients with end-stage renal disease: a prospective proof-of-concept study,"Cardiorenal medicine 7 (1), 50-59",4,2016,7,"D Habedank, JC Schefold, C Bernhardt, T Karhausen, W Doehner, ...", Stefan D Anker
Stefan D. Anker,"Moving upwards–the journal of cachexia, sarcopenia and muscle in 2016","Journal of Cachexia, Sarcopenia and Muscle 7 (4), 391",4,2016,3,"S von Haehling, N Ebner, SD Anker", Stefan D Anker
Stefan D. Anker,The Syndrome of Heart Failure With Preserved Systolic Function.,"Revista Espanola de Cardiologia (English ed.) 70 (4), 232-233",4,2016,3,"CM Sarwar, J Butler, SD Anker", Stefan D Anker
Stefan D. Anker,Iron deficiency independently and strongly predicts risk of cardiovascular death and myocardial infarction in patients with acute coronary syndrome,"Circulation 134 (suppl_1), A18474-A18474",4,2016,9,"M Karakas, C Waldeyer, F Ojeda, R Schnabel, K Lackner, S Anker, ...", Stefan Anker
Stefan D. Anker,Central chemoreceptor sensitivity is not enhanced in contemporary patients with chronic systolic heart failure receiving optimal treatment,"Journal of Cardiac Failure 23 (1), 83-87",4,2017,10,"B Paleczny, M Olesińska, A Siennicka, P Niewiński, EA Jankowska, ...", Stefan D Anker
Stefan D. Anker,Resting heart rate and ischemic stroke in patients with heart failure,"Cerebrovascular Diseases 44 (1-2), 43-50",4,2017,21,"K Nakanishi, MR Di Tullio, M Qian, JLP Thompson, AJ Labovitz, DL Mann, ...", Stefan D Anker
Stefan D. Anker,Association between serum potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry,"Journal of the American College of Cardiology 69 (11S), 678-678",4,2017,12,"LB Cooper, L Benson, R Mentz, G Savarese, A DeVore, JJ Carrero, ...", Stefan Anker
Stefan D. Anker,"Design and rationale of the EMPEROR trials of, empagliflozin 10 mg once daily, in patients with chronic heart failure with reduced ejection fraction (EMPEROR-Reduced) or …","Diabetologie und Stoffwechsel 14 (S 01), P 106",4,2019,12,"S Anker, F Zannad, J Butler, G Filippatos, A Salsali, K Kimura, J Schnee, ...",S Anker
Stefan D. Anker,Design and rationale of the EMPagliflozin outcome trial in patients with chronic heart failure (EMPEROR-reduced),"European Journal of Heart Failure 20, 441-441",4,2018,12,"FF Zannad, G Filippatos, J Butler, A Salsali, K Kimura, J Schnee, C Zeller, ...", SD Anker
Stefan D. Anker,"Employment Cost Index, Historical Listing–Volume V: Continuous Occupational and Industry Series: September 1975-December 2017. Table 4: employment cost index for total…",RTI International,4,2019,48,"EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ...",
Stefan D. Anker,Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology-Heart Failure Association EURObservational …,"ESC HEART FAILURE 7 (5), 2098-2112",4,2020,18,"A Kaplon-Cieslicka, C Laroche, MG Crespo-Leiro, AJS Coats, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Education and certification on heart failure of the H eart F ailure A ssociation of the E uropean S ociety of C ardiology,"European journal of heart failure 24 (2), 249-253",4,2022,42,"W Mullens, A Coats, P Seferovic, M Metra, A Mebazaa, F Ruschitzka, ...", Stefan D Anker
Stefan D. Anker,Cachexia: time to receive more attention,"International Journal of Cardiology 85 (1), 5-6",5,2002,1,SD Anker,Stefan D Anker
Stefan D. Anker,Statins and survival in 2068 CHF patients with ischemic and non-ischemic etiology,"Circulation 106 (19), 513-513",5,2002,12,"SD Anker, AL Clark, C Kilkowski, C Zugck, M Cicoira, P Ponikowski, ...",SD Anker
Stefan D. Anker,Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern,"American Journal of Cardiology 91 (10), 1281-1283",5,2003,7,"F Al-Nasser, M Yousufuddin, F Al-Nozha, SD Anker, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,Hemoglobin level is associated with adverse outcomes in patients with severe chronic heart failure: Results from the COPERNICUS Study,"Journal of Cardiac Failure 9 (5), S58",5,2003,5,"S Anker, AJS Coats, EB Roecker, P Mohacsi, M Packer",Stefan Anker
Stefan D. Anker,Body composition and survival in 511 chronic heart failure patients,"EUROPEAN HEART JOURNAL 25, 356-356",5,2004,8,"M Cicoira, E Jankowska, W Doehner, L Zanolla, W Banasiak, ...", SD Anker
Stefan D. Anker,Future perspectives on treatment with erythropoiesis-stimulating agents in high-risk patients,"NDT plus 2 (suppl_1), i3-i8",5,2009,2,"SD Anker, R Toto",Stefan D Anker
Stefan D. Anker,Erythropoietin in kidney disease and type 2 diabetes.,"The New England journal of medicine 364 (4), 384-385",5,2011,3,"T Thum, K Kalantar-Zadeh, SD Anker", Stefan D Anker
Stefan D. Anker,The impact of remote telemedical management on mortality & hospitalization rates in ambulatory patients with CHF,The Telemedicine to Improve Mortality in Heart Failure study (TIM-HF). Chicago,5,2010,14,"F Koehler, S Winkler, M Schieber, U Sechtem, K Stangl, M Böhm, H Boll, ...", Stefan D Anker
Stefan D. Anker,Limitations of gait speed as an independent predictor of mortality and morbidity in cardiac patients,"Journal of the American College of Cardiology 58 (7), 776-776",5,2011,3,"T Thum, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,DGEM (German Society for Nutritional Medicine) ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN guidelines on enteral nutrition: cardiology and pulmonology,"Clin Nutr 25, 311-318",5,2006,6,"SD Anker, M John, PU Pedersen, C Raguso, M Cicoira, E Dardai",SD Anker
Stefan D. Anker,ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 [published correction appears in Eur Heart J. 2013; 34: 158],"Eur Heart J 33, 1787-1847",5,2012,3,"JJ McMurray, S Adamopoulos, SD Anker", SD Anker
Stefan D. Anker,ESC of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology …,"Eur Heart J 33, 1787-1847",5,2012,6,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Bohm, ...", SD Anker
Stefan D. Anker,Atorvastatin modulates constitutive and lipopolysaccharide induced IL-6 secretion in precursors of human skeletal muscle,"African Journal of Pharmacy and Pharmacology 6 (4), 241-247",5,2012,6,"A Golicnik, M Podbregar, M Lainscak, SD Anker, Z Grubic, T Mars", Stefan D Anker
Stefan D. Anker,Commentary on the 2010 ESC guidelines on device therapy in heart failure,"Der Kardiologe 6, 5-11",5,2012,3,"CW Israel, SD Anker, G Hasenfuss", SD Anker
Stefan D. Anker,C-terminal agrin-fragment as a novel diagnostic marker for muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities …,"European Heart Journal 34 (suppl_1), P5077",5,2013,8,"L Steinbeck, N Ebner, M Valentova, A Sandek, T Bekfani, W Doehner, ...", SD Anker
Stefan D. Anker,The Joint Task Force on non-cardiac surgery: car diovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology …,"Eur Heart J 35, 2383-431",5,2014,6,"SD Kristesen, J Knuuti, A Saraste, S Anker, HE Botker, S De Heart", S Anker
Stefan D. Anker,Adaptive licensing—A way forward in the approval process of new therapeutic agents in Europe,"International Journal of Cardiology 184, 568-569",5,2015,4,"GMC Rosano, SD Anker, W Marrocco, AJS Coats", Stefan D Anker
Stefan D. Anker,"More colour to the Journal: new style, new publisher, but still Cachexia, Sarcopenia and Muscle","Journal of Cachexia, Sarcopenia and Muscle 6 (1), 1",5,2015,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Role of microRNAs in wasting in heart failure,"Nature Reviews Cardiology 14 (9), 566-566",5,2017,5,"S Von Haehling, N Ebner, MR Dos Santos, J Springer, SD Anker", Stefan D Anker
Stefan D. Anker,The times they are a-changin': The Cachexia Conference goes annual,Wiley-blackwell,5,2016,2,"S von Haehling, SD Anker", Stefan-D Anker
Stefan D. Anker,Use of ACE inhibitors or angiotensin receptor blockers is associated with a significantly lower risk of 30-day all-cause and heart failure readmissions and all-cause mortality …,"Circulation 132 (suppl_3), A19094-A19094",5,2015,18,"M Siddiqui, PW Sanders, G Arora, C Morgan, S Zhang, SD Prabhu, ...", Stefan D Anker
Stefan D. Anker,Design and rationale of the EMPagliflozin outcomE tRial in patients with chrOnic heaRt failure (EMPEROR-preserved),"Eur J Heart Fail 20 (S1), 972",5,2018,12,"J Butler, M Packer, G Filippatos, F Zannad, A Salsali, K Kimura, J Schnee, ...", SD Anker
Stefan D. Anker,"Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018","Journal of Cachexia, Sarcopenia and Muscle 9 (5), 793",5,2018,4,"S von Haehling, MS Anker, N Ebner, SD Anker", Markus S Anker
Stefan D. Anker,The evolving obesity paradigm story: from heart failure to atrial fibrillation,"European Heart Journal 40 (19), 1550-1552",5,2019,3,"S von Haehling, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,"The Journal of Cachexia, Sarcopenia and Muscle stays the front‐runner in geriatrics and gerontology","Journal of Cachexia, Sarcopenia and Muscle 10 (6), 1151",5,2019,4,"MS Anker, SD Anker, AJS Coats, S von Haehling",Markus S Anker
Stefan D. Anker,Heart failure and cardiac events: is a consecutive measurement of biomarkers a simple and practical approach?,"Thrombosis and haemostasis 119 (12), 1891-1893",5,2019,2,"JM Rivera-Caravaca, MA Esteve-Pastor",
Stefan D. Anker,Prevalence of risk of thrombosis and of bleeding and antithrombotic treatment in patients with heart failure,"European journal of heart failure 22 (5), 906-910",5,2020,15,"M Pozzoli, J Gonzalez-Costello, A Bayes-Genis, G Sinagra, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Can we trust a smartwatch ECG? Potential and limitations,"European Journal of Heart Failure 23, 850-853",5,2021,3,"W Haverkamp, J Butler, SD Anker", Stefan D Anker
Stefan D. Anker,"Heart failure re-hospitalizations and subsequent fatal events in coronary artery disease: insights from COMMANDER-HF, EPHESUS, and EXAMINE","Clinical Research in Cardiology, 1-10",5,2021,11,"JP Ferreira, JG Cleland, CSP Lam, SD Anker, MR Mehra, ...", Stefan D Anker
Stefan D. Anker,FC 090 Effects of finerenone on cardiorenal outcomes in blood pressure subgroups in patients with CKD and T2D,"Nephrology Dialysis Transplantation 36 (Supplement_1), gfab149. 002",5,2021,12,"L Ruilope, R Agarwal, SD Anker, G Filippatos, B Pitt, P Rossing, ...", Stefan D Anker
Stefan D. Anker,Finerenone in Patients with CKD and Type 2 Diabetes by SGLT-2i Treatment: The FIDELITY Analysis: SA-OR22,"Journal of the American Society of Nephrology 32 (10S), 45",5,2021,11,"P Rossing, G Filippatos, GL Bakris, SD Anker, B Pitt, LM Ruilope, M Gebel, ...", Stefan D Anker
Stefan D. Anker,Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action,"Critical Reviews in Oncology/Hematology, 103965",5,2023,12,"J Arends, M Muscaritoli, S Anker, R Audisio, R Barazzoni, S Bosnjak, ...", Stefan Anker
Stefan D. Anker,The small molecule ACM‐001 improves cardiac function in a rat model of severe cancer cachexia,"European Journal of Heart Failure 25 (5), 673-686",5,2023,8,"MS Poetsch, S Palus, S Van Linthout, S von Haehling, W Doehner, ...", Stefan D Anker
Stefan D. Anker,"Recency of heart failure hospitalization, outcomes, and the effect of empagliflozin: an EMPEROR-Pooled analysis","Heart Failure 11 (6), 702-712",5,2023,11,"JP Ferreira, F Zannad, J Butler, G Filippatos, S Pocock, T Iwata, M Sumin, ...", Stefan D Anker
Stefan D. Anker,Iron deficiency as a promoter of cardiotoxicity: not only cadmium-induced,"European Heart Journal 44 (28), 2641-2641",5,2023,3,"G Savarese, MS Anker, SD Anker", Markus S Anker
Stefan D. Anker,Patient‐reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre‐terminal cancer,"Journal of Cachexia, Sarcopenia and Muscle 14 (4), 1670-1681",5,2023,25,"MS Anker, A Lena, EJ Roeland, J Porthun, S Schmitz, S Hadzibegovic, ...",Markus S Anker
Stefan D. Anker,Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in‐hospital and long‐term outcomes–from the ESC‐HFA EORP Heart …,"European Journal of Heart Failure 25 (9), 1571-1583",5,2023,150,"A Kapłon‐Cieślicka, L Benson, O Chioncel, MG Crespo‐Leiro, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,Modifiability of composite cardiovascular risk associated with chronic kidney disease in type 2 diabetes with finerenone,"JAMA cardiology 8 (8), 732-741",5,2023,15,"R Agarwal, B Pitt, P Rossing, SD Anker, G Filippatos, LM Ruilope, ...", Stefan D Anker
Stefan D. Anker,Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table,"European Heart Journal 44 (39), 4141-4156",5,2023,21,"F Cosentino, S Verma, P Ambery, MB Treppendahl, M Van Eickels, ...", Stefan D Anker
Stefan D. Anker,"Epidemiology, pathophysiology, diagnosis and management of chronic right‐sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure …","European journal of heart failure 26 (1), 18-33",5,2024,37,"M Adamo, O Chioncel, M Pagnesi, A Bayes‐Genis, M Abdelhamid, ...", Stefan D Anker
Stefan D. Anker,Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized …,"Clinical Research in Cardiology 112 (11), 1620-1638",5,2023,15,"U Rauch-Kröhnert, M Puccini, M Placzek, J Beyer-Westendorf, K Jakobs, ...", Stefan D Anker
Stefan D. Anker,CANTOS Trial Group 2017,Antiinflammatory therapy with canakinumab for atherosclerotic disease. N …,6,,10,"PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...", SD Anker
Stefan D. Anker,ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2016: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the …,,6,,3,"P Ponikowski, S Anker, AA Voors", S Anker
Stefan D. Anker,Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction,"Circulation 95 (2), 538-539",6,1997,2,"SD Anker, AJ Coats",Stefan D Anker
Stefan D. Anker,Tumor necrosis factor alpha in chronic heart failure. Clinical manifestation and therapeutic possibilities,"Herz 26 (7), 437-446",6,2001,3,"S Genth-Zotz, AP Bolger, SD Anker", Stefan D Anker
Stefan D. Anker,The significance of Leptin in human—do we know it yet?,"International journal of cardiology 76 (2), 122-124",6,2000,2,"W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Anti-tumour necrosis factor therapy-in chronic heart failure-what went wrong?,"Heart Failure Updates, 213-226",6,2003,1,SD Anker,Stefan D Anker
Stefan D. Anker,Heat shock proteins and endotoxin combined as a trigger for inflammatory cytokine release during cardiopulmonary bypass: a possible third way?,"Circulation 106 (11), e49-e50",6,2002,3,"AP Bolger, S Genth-Zotz, SD Anker", Stefan D Anker
Stefan D. Anker,The Syndrome of Cardiac Cachexia,"The Role of Inflammatory Mediators in the Failing Heart, 93-103",6,1997,2,"SD Anker, R Sharma",Stefan D Anker
Stefan D. Anker,Cachexia and cardiology.,"Circulation 113 (14), f53-4",6,2006,1,S Anker,Stefan Anker
Stefan D. Anker,The xanthine oxidase inhibitors oxypurinol and allopurinol reduce wasting and improve cardiac function in experimental cancer cachexia,"Journal of cardiac failure 15 (6), S22",6,2009,7,"J Springer, A Hartmann, S Palus, V Adams, R von Harsdorf, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Action Profile of the Antiobesity Drug Candidate Oleoyl‐Estrone in Rats,"Obesity 18 (12), 2260-2267",6,2010,8,"S Strassburg, PT Pfluger, N Chaudhary, P Tso, MH Tschöp, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Improved survival in patients with diastolic heart failure discharged on beta-blocker and ace inhibitors,"Journal of the American College of Cardiology 61 (10S), E634-E634",6,2013,16,"K Shah, N Parekh, P Clopton, I Anand, R Christenson, L Daniels, ...", Stefan Anker
Stefan D. Anker,"Survival and Quality of Life Data from the Act One Randomised, Double-Blind, Placebo-Controlled, Phase Ii Study of Espindolol for the Treatment and Prevention of Cachexia in …","Annals of Oncology 25, iv162",6,2014,7,"J Beadle, A Coats, GF Ho, K Prabhash, S von Haeling, R Brown, S Anker", S Anker
Stefan D. Anker,"Ghrelin. Molecular Metabolism, 4 (6), 437e460",,6,2015,7,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,The Management of Co-Morbidities in Patients with Heart Failure-Iron Deficiency,International Cardiovascular Forum Journal 10,6,2017,3,"S von Haehling, E Jankowska, SD Anker", Stefan D Anker
Stefan D. Anker,Diabetes and heart failure: sugared words prove bitter,"Journal of the American College of Cardiology 68 (13), 1417-1419",6,2016,3,"S von Haehling, G Hasenfuss, SD Anker", Stefan D Anker
Stefan D. Anker,Avrupa Kardiyoloji Derneği (ESC) Akut ve Kronik Kalp Yetersizliği Tani ve Tedavisi 2012 Görev Grubu; ESC Kalp Yetersizliği Birliğinin Işbirliğiyle hazirlanmiştir,Heart Failure Association. ESC Guidelines for the diagnosis and treatment of …,6,2012,25,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Böhm, ...", SD Anker
Stefan D. Anker,Andropausal syndrome in men with systolic heart failure,"Pol Arch Med Wewn 123 (4), 156-69",6,2013,12,"M Tkaczyszyn, K Nega, M Łopuszańska, A Szklarska, M Mędraś, ...", Stefan D Anker
Stefan D. Anker,"B€ ohm M., Dickstein K.… Zeiher A.; ESC Committee for Practice Guidelines.(2012)",ESC Guidelines for the diagnosis and treatment of acute and chronic heart …,6,2012,4,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio", SD Anker
Stefan D. Anker,Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. Reply.,"The New England Journal of Medicine 384 (11), e42-e42",6,2021,3,"GL Bakris, R Agarwal, G Filippatos",
Stefan D. Anker,Expect the unexpected in the medical treatment of heart failure with reduced ejection fraction: between scientific evidence and clinical wisdom,"International Journal of Heart Failure 3 (4), 205",6,2021,6,"PM Seferovic, M Polovina, I Milinkovic, S Anker, G Rosano, A Coats", Stefan Anker
Stefan D. Anker,Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium,"American Heart Journal 248, 108-119",6,2022,13,"MZ Israr, H Zhan, A Salzano, AA Voors, JG Cleland, SD Anker, M Metra, ...", Stefan D Anker
Stefan D. Anker,"Obesity, heart failure, and SGLT2 inhibition: DECLARE-TIMI 58 provides insights","European Heart Journal 43 (31), 2968-2970",6,2022,4,"N Sattar, SD Anker, J Butler, S Verma", Stefan D Anker
Stefan D. Anker,Association of finerenone use with reduction in treatment-emergent pneumonia and COVID-19 adverse events among patients with type 2 diabetes and chronic kidney disease: a …,"JAMA network open 5 (10), e2236123-e2236123",6,2022,11,"B Pitt, R Agarwal, SD Anker, LM Ruilope, P Rossing, C Ahlers, M Brinker, ...", Stefan D Anker
Stefan D. Anker,Role of cardiac contractility modulation in heart failure with a higher ejection fraction,"Journal of cardiac failure 28 (12), 1717-1726",6,2022,8,"KM Talha, SD Anker, D Burkhoff, G Filippatos, CSP Lam, GW Stone, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in black versus white patients with heart failure: analysis of EMPEROR-pooled,"Circulation 147 (1), 101-104",6,2023,16,"S Verma, NK Dhingra, J Butler, SD Anker, J Pedro Ferreira, G Filippatos, ...", Stefan D Anker
Stefan D. Anker,Comparison of investigator-reported and centrally adjudicated heart failure outcomes in the EMPEROR-reduced trial,"Heart Failure 11 (4), 407-417",6,2023,17,"P Carson, JR Teerlink, M Komajda, I Anand, SD Anker, J Butler, ...", Stefan D Anker
Stefan D. Anker,The atypical β‐blocker S‐oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model,"Journal of Cachexia, Sarcopenia and Muscle 14 (1), 653-660",6,2023,16,"L Yuan, J Springer, S Palus, S Busquets, Q Jové, E Alves de Lima Junior, ...", Markus S Anker
Stefan D. Anker,"Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017","Journal of Cachexia, Sarcopenia and Muscle 8 (5), 675",7,2017,3,"S von Haehling, N Ebner, SD Anker", Stefan D Anker
Stefan D. Anker,The ethics of conducting clinical trials with sodium-glucose cotransporter-2 inhibitors in heart failure: is placebo assignment justified in patients with comorbid diabetes …,"Circulation 136 (16), 1459-1461",7,2017,2,"J Butler, SD Anker", Stefan D Anker
Stefan D. Anker,Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?,"ESC Heart Failure 5 (3), 309-315",7,2018,7,"M Möckel, S von Haehling, JO Vollert, JC Wiemer, SD Anker, A Maisel, ...", Stefan D Anker
Stefan D. Anker,Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design,"ESC Heart Failure 6 (5), 1077-1084",7,2019,5,"M Lainscak, D Omersa, N Sedlar, SD Anker, J Farkas", Stefan D Anker
Stefan D. Anker,Liraglutide for adolescents with obesity,"N Engl J Med 383 (12), 1192",7,2020,3,"MS Anker, J Butler, SD Anker",Markus S Anker
Stefan D. Anker,Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure,"Clinical proteomics 15, 1-9",7,2018,22,"TH Cao, DJL Jones, PA Quinn, DCS Chan, N Hafid, HM Parry, M Mohan, ...", Stefan D Anker
Stefan D. Anker,Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study,"Clinical Research in Cardiology 109, 967-977",7,2020,15,"CM Lombardi, JP Ferreira, V Carubelli, SD Anker, JG Cleland, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Reporting and interpretation of subgroup analyses in heart failure randomized controlled trials,"ESC heart failure 8 (1), 26-36",7,2021,12,"MS Khan, MAA Khan, S Irfan, TJ Siddiqi, SJ Greene, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Effect of Carillon Mitral Contour System on patient‐reported outcomes in functional mitral regurgitation: an individual participant data meta‐analysis,"ESC Heart Failure 8 (3), 1885-1891",7,2021,4,"MS Khan, T Friede, SD Anker, J Butler", Stefan D Anker
Stefan D. Anker,Feasibility of remote speech analysis in evaluation of dynamic fluid overload in heart failure patients undergoing haemodialysis treatment,"ESC Heart Failure 8 (4), 2467-2472",7,2021,10,"O Amir, SD Anker, I Gork, WT Abraham, SP Pinney, D Burkhoff, ...", Stefan D Anker
Stefan D. Anker,Iron deficiency and reduced muscle strength in patients with acute and chronic ischemic stroke,"Journal of Clinical Medicine 11 (3), 595",7,2022,8,"N Scherbakov, A Sandek, M Valentova, A Mayer, S von Haehling, ...", Stefan D Anker
Stefan D. Anker,Assessment of proximal tubular function by tubular maximum phosphate reabsorption capacity in heart failure,"Clinical Journal of the American Society of Nephrology 17 (2), 228-239",7,2022,16,"JE Emmens, MH De Borst, EM Boorsma, K Damman, G Navis, ...", Stefan D Anker
Stefan D. Anker,Hormonal changes in cardiac cachexia,"Circulation 92 (8), 988-988",8,1995,6,"SD Anker, M VOLTERANI, JW Swan, TP Chua, PA POOLEWILSON, ...",SD Anker
Stefan D. Anker,Cardiac cachexia,"Chest 115 (3), 836-847",8,1999,2,"SD Anker, AJS Coats",Stefan D Anker
Stefan D. Anker,Plasma concentrations of bacterial lipopolysaccharide: A marker of infection or inflammation?,"heart failure 79, 1426-30",8,1997,1,D Street,
Stefan D. Anker,Chronic heart failure and cardiac cachexia and links between the endocrine and immune systems,"Zeitschrift für Kardiologie 88 (Suppl 3), S018-S023",8,1999,2,"SD Anker, M Cicoira",SD Anker
Stefan D. Anker,The relationship between hemoglobin and exercise capacity in patients with stable chronic heart failure (CHF),"Circulation 106 (19), 570-570",8,2002,8,"PR Kalra, AP Bolger, R Sharma, S Genth-Zotz, W Doehner, ...", SD Anker
Stefan D. Anker,Targeting the Toll-System in cardiovascular sciences,"Recent patents on inflammation & allergy drug discovery 1 (1), 57-67",8,2007,4,"G Foldes, S von Haehling, EA Jankowska, SD Anker", Stefan D Anker
Stefan D. Anker,Impact of neurohormonal blockade on association between body mass index and mortality,"International journal of cardiology 119 (1), 33-40",8,2007,5,"LMA Kennedy, SD Anker, J Kjekshus, TJ Cook, R Willenheimer", Stefan D Anker
Stefan D. Anker,Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure,"Journal of cardiac failure 15 (6), 551",8,2009,3,"G Földes, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,"Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, JJ Bax, H",,8,2012,26,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Böhm, ...", SD Anker
Stefan D. Anker,Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly?,"The Aging Male 16 (3), 123-131",8,2013,11,"E Kalicińska, K Wojtas, J Majda, W Doehner, S Haehling, W Banasiak, ...", Stefan D Anker
Stefan D. Anker,"Recommendations on diabetes, prediabetes and cardiovascular disease","Rus. J. Cardiol 3, 7-61",8,2014,7,"L Rydén, PJ Grant, SD Anker, C Berne, F Cosentino, N Danchin, ...", SD Anker
Stefan D. Anker,Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease,"US Patent 8,647,830",8,2014,5,"A Bergmann, J Papassotiriou, J Struck, N Morgenthaler, S Anker", Stefan Anker
Stefan D. Anker,Association of quality of life with anticoagulant control in patients with heart failure: the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) trial,"International journal of cardiology 177 (2), 715-717",8,2014,18,"JA Shaffer, JLP Thompson, B Cheng, S Ye, GYH Lip, DL Mann, RL Sacco, ...", Stefan D Anker
Stefan D. Anker,Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure,"Croatian medical journal 56 (6), 531-541",8,2015,7,"K Cvan Trobec, M Kerec Kos, S Haehling, SD Anker, IC Macdougall, ...", Stefan D Anker
Stefan D. Anker,Six1 is down‐regulated in end‐stage human dilated cardiomyopathy independently of Ezh2,"ESC heart failure 1 (2), 154-159",8,2014,6,"A Tschirner, S Palus, R Hetzer, R Meyer, SD Anker, J Springer", Stefan D Anker
Stefan D. Anker,Grupo de Trabajo Conjunto sobre cirugía no cardiaca: Evaluación y manejo cardiovascular de la Sociedad Europea de Cardiología (ESC) y la European Society of Anesthesiology (ESA),"Revista Española de Cardiología 67 (12), 1052. e1-1052. e43",8,2014,24,"SD Kristensen, J Knuuti, A Saraste, S Anker, HE Bøtker, S De Hert, I Ford, ...", Stefan Anker
Stefan D. Anker,Iron deficiency in chronic heart failure: diagnostic algorithm and present-day therapeutic options,"Deutsche Medizinische Wochenschrift (1946) 142 (10), 752-757",8,2017,12,"W Doehner, S Blankenberg, E Erdmann, G Ertl, G Hasenfuss, ...", Stefan D Anker
Stefan D. Anker,New treatments for hyperkalaemia: clinical use in cardiology,"European Heart Journal Supplements 21 (Supplement_A), A41-A47",8,2019,3,"S Vijayakumar, J Butler, SD Anker", Stefan D Anker
Stefan D. Anker,Heart failure and sleep‐disordered breathing: susceptibility to reduced muscle strength and preclinical congestion (SICA‐HF cohort),"ESC Heart Failure 7 (5), 2063-2070",8,2020,9,"T Bekfani, C Schöbel, C Pietrock, M Valentova, N Ebner, W Döhner, ...", Stefan D Anker
Stefan D. Anker,Spontaneous non-sustained ventricular tachycardia and premature ventricular contractions and their prognostic relevance in patients with cancer in routine care,"Cancers 13 (10), 2303",8,2021,13,"A Albrecht, J Porthun, J Eucker, AJS Coats, S von Haehling, A Pezzutto, ...", Stefan D Anker
Stefan D. Anker,Stroke in hemodialysis patients randomized to different intravenous iron strategies: a prespecified analysis from the PIVOTAL trial,"Kidney360 2 (11), 1761-1769",8,2021,18,"PB Mark, PS Jhund, MR Walters, MC Petrie, A Power, C White, ...", Stefan D Anker
Stefan D. Anker,Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure,"European Journal of Heart Failure 24 (11), 2131-2139",8,2022,17,"RM Inciardi, M Pagnesi, CM Lombardi, SD Anker, JG Cleland, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients,"American Journal of Transplantation 22 (12), 3078-3086",8,2022,14,"FL Scolari, DH Brahmbhatt, S Abelson, JJF Medeiros, MS Anker, NL Fung, ...", Markus S Anker
Stefan D. Anker,Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in …,"Clinical Research in Cardiology 108, 797-805",8,2019,22,"IR Mordi, BT Santema, M Kloosterman, AM Choy, M Rienstra, I van Gelder, ...", Stefan D Anker
Stefan D. Anker,Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved,"Nature medicine 28 (12), 2512-2520",8,2022,35,"SD Anker, J Butler, MS Usman, G Filippatos, JP Ferreira, E Bocchi, ...",Stefan D Anker
Stefan D. Anker,Hypokalaemia and outcomes in older patients hospitalized for heart failure,"ESC heart failure 7 (3), 794-803",8,2020,11,"M Valentova, S Patel, PH Lam, C Faselis, C Arundel, GC Fonarow, ...", Stefan D Anker
Stefan D. Anker,Pathophysiological pathways in patients with heart failure and atrial fibrillation,"Cardiovascular Research 118 (11), 2478-2487",8,2022,22,"BT Santema, VA Arita, IE Sama, M Kloosterman, MP van den Berg, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation,"European journal of heart failure 25 (7), 970-977",8,2023,12,"G Filippatos, D Farmakis, J Butler, F Zannad, JP Ferreira, AP Ofstad, ...", Stefan D Anker
Stefan D. Anker,A global survey of health care workers' awareness of non‐alcoholic fatty liver disease: The AwareNASH survey,"United European gastroenterology journal 11 (7), 654-662",8,2023,12,"S Driessen, VD de Jong, KC van Son, T Klompenhouwer, Y Colardelle, ...", Stefan D Anker
Stefan D. Anker,"Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, Harrington D, Kox WJ, Poole-Wilson PA, and Coats AJ",Wasting as independent risk factor for mortality in chronic heart failure …,9,1997,1,SD Anker,SD Anker
Stefan D. Anker,Endotoxemia in congestive heart failure: highest levels in hepatic veins suggestive of intestinal bacterial and/or endotoxin translocation,"European Journal of Heart failure 2, 88-88",9,2000,5,"T Peschel, SD Anker, K Ziegenbalg, M Schönauer, J Niebauer", SD Anker
Stefan D. Anker,Wasting as predictor of survival in CF,"Thorax 57 (5), 468-468",9,2002,2,"P Aurora, A Wade",
Stefan D. Anker,Impact of statin therapy on clinical outcomes in CHF patients according to beta-blocker use: results of CIBISII,"EUROPEAN HEART JOURNAL 25, 246-246",9,2004,7,"H Krum, M Bailey, W Meyer, P Verkenne, H Dargie, P Lechat, S Anker", S Anker
Stefan D. Anker,Pharmacotherapy of cachexia,CRC Press,9,2005,4,"KG Hofbauer, SD Anker, A Inui, JR Nicholson", Stefan D Anker
Stefan D. Anker,Obesity and risk of myocardial infarction: the INTERHEART study,"The Lancet 367 (9516), 1051-1052",9,2006,2,"T Thum, SD Anker", Stefan D Anker
Stefan D. Anker,Overview of emerging pharmacotherapy in chronic heart failure,"Expert Opinion on Pharmacotherapy 10 (13), 2055-2074",9,2009,6,"T Szabó, D Felger, S von Haehling, M Lainscak, SD Anker, W Doehner", Stefan D Anker
Stefan D. Anker,Muscle in heart disease: Highlights from the European Society of Cardiology's Annual Meeting 2012,"International journal of cardiology 161 (3), 126-129",9,2012,3,"A Sandek, S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Iron deficiency in chronic heart failure: from diagnosis to therapy,"Deutsche Medizinische Wochenschrift (1946) 139 (16), 841-844",9,2014,2,"S Von Haehling, SD Anker", SD Anker
Stefan D. Anker,Multimodal management as requirement for the clinical use of anticachexia drugs-a regulatory and a clinical perspective,"Current opinion in supportive and palliative care 9 (4), 333-345",9,2015,5,"JJ Borg, SD Anker, G Rosano, A Serracino-Inglott, F Strasser", Stefan D Anker
Stefan D. Anker,Evaluación económica de la utilización de hierro carboximaltosa en pacientes con deficiencia de hierro e insuficiencia cardiaca crónica en España,"Revista Española de Cardiología 68 (10), 846-851",9,2015,7,"J Comín-Colet, D Rubio-Rodríguez, C Rubio-Terrés, C Enjuanes-Grau, ...", Stefan D Anker
Stefan D. Anker,Advances in cachexia and sarcopenia research in the heart failure context: call for action,"Journal of Cardiovascular Medicine 17 (12), 860-862",9,2016,3,"J Springer, MS Anker, SD Anker", Markus S Anker
Stefan D. Anker,The obesity paradigm and lifetime risk of cardiovascular disease,"JAMA cardiology 3 (9), 895-896",9,2018,3,"W Doehner, K Kalantar-Zadeh, SD Anker", Stefan D Anker
Stefan D. Anker,Novel potassium binders as enabling therapy in heart failure,"European Journal of Heart Failure 21 (5), 550-552",9,2019,3,"J Butler, MS Khan, SD Anker", Stefan D Anker
Stefan D. Anker,Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II,"EP Europace 22 (6), 932-938",9,2020,11,"C Normand, C Linde, C Blomström-Lundqvist, C Stellbrink, M Gasparini, ...", Stefan D Anker
Stefan D. Anker,Implications of serial measurements of natriuretic peptides in heart failure: insights from BIOSTAT-CHF,"European journal of heart failure 22 (8), 1486-1490",9,2020,13,"MZ Israr, A Salzano, Y Yazaki, AA Voors, W Ouwerkerk, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Roxadustat for anemia in patients with chronic kidney disease,"N Engl J Med 383 (1), e3",9,2020,3,"MS Anker, J Butler, SD Anker",Markus S Anker
Stefan D. Anker,Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature,"ESC Heart Failure 8 (6), 4717-4736",9,2021,15,"RI Radu, T Ben Gal, M Abdelhamid, EL Antohi, M Adamo, AP Ambrosy, ...", Stefan D Anker
Stefan D. Anker,Prognostic impact of 6 min walk test distance in patients with systolic heart failure: insights from the WARCEF trial,"ESC Heart Failure 8 (2), 819-828",9,2021,10,"K Matsumoto, Y Xiao, S Homma, JLP Thompson, R Buchsbaum, K Ito, ...", Stefan D Anker
Stefan D. Anker,"Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies","ESC Heart Failure 7 (5), 3086-3094",9,2020,13,"GWP Fonseca, T Garfias Macedo, N Ebner, MR Dos Santos, FR de Souza, ...", Stefan D Anker
Stefan D. Anker,Discontinuation and non‐publication of heart failure randomized controlled trials: a call to publish all trial results,"ESC heart failure 8 (1), 16-25",9,2021,11,"MS Khan, I Shahid, N Asad, SJ Greene, SU Khan, R Doukky, M Metra, ...", Stefan D Anker
Stefan D. Anker,Safety and efficacy of iron supplementation after myocardial infarction in mice with moderate blood loss anaemia,"ESC Heart Failure 8 (6), 5445-5455",9,2021,9,"P Wischmann, R Chennupati, I Solga, F Funk, S Becher, N Gerdes, ...", Stefan Anker
Stefan D. Anker,Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon‐like peptide‐1 receptor agonist use,"Diabetes, Obesity and Metabolism 25 (2), 407-416",10,2023,14,"P Rossing, R Agarwal, SD Anker, G Filippatos, B Pitt, LM Ruilope, ...", Stefan D Anker
Stefan D. Anker,Percutaneous mitral valve annuloplasty in patients with secondary mitral regurgitation and severe left ventricular enlargement,"Heart Failure 9 (6), 453-462",9,2021,9,"SD Anker, RC Starling, MS Khan, T Friede, G Filippatos, JA Lindenfeld, ...",Stefan D Anker
Stefan D. Anker,The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies,"Clinical Research in Cardiology 112 (7), 923-941",10,2023,90,"J Hoffmann, S Hanß, M Kraus, J Schaller, C Schäfer, D Stahl, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Baseline characteristics of patients enrolled in the EMPACT‐MI trial,"European Journal of Heart Failure 25 (9), 1708-1715",10,2023,11,"J Harrington, JA Udell, WS Jones, SD Anker, DL Bhatt, MC Petrie, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin after acute myocardial infarction,"N Engl J Med 390 (16), 1455-1466",10,2024,41,"J Butler, WS Jones, JA Udell, SD Anker, MC Petrie, J Harrington, ...", Stefan D Anker
Stefan D. Anker,Clinical significance of impaired insulin sensitivity in chronic heart failure,"Circulation 102 (18), 719-719",11,2000,8,"W Doehner, M Rauchhaus, IF Godsland, CH Davos, AJ Proudler, ...", SD Anker
Stefan D. Anker,Bleeding risk and antithrombotic strategy in patients with sinus rhythm and heart failure with reduced ejection fraction treated with warfarin or aspirin,"The American journal of cardiology 116 (6), 904-912",11,2015,22,"S Ye, B Cheng, GYH Lip, R Buchsbaum, RL Sacco, B Levin, MR Di Tullio, ...", Stefan D Anker
Stefan D. Anker,"ArgilÃ© s J, Aversa Z, Bauer JM, Biolo G, et al","Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint …",11,2010,2,"M Muscaritoli, SD Anker", SD Anker
Stefan D. Anker,Prevention and treatment of sarcopenia,"US Patent 8,835,485",11,2014,4,"J Springer, S Anker, A Coats, J Beadle", Stefan Anker
Stefan D. Anker,Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients,"US Patent 8,252,544",11,2012,5,"A Bergmann, N Morgenthaler, J Papassotiriou, J Struck, S Anker", Stefan Anker
Stefan D. Anker,Anemia and inflammation in chronic heart failure,"Journal of Cardiac Failure 9 (5), S33",11,2003,6,"A Bolger, S Haehling, W Doehner, PA Poole-Wilson, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure,"International journal of cardiology 219, 84-91",11,2016,10,"J Kube, N Ebner, EA Jankowska, P Rozentryt, M Cicoira, GS Filippatos, ...", Stefan D Anker
Stefan D. Anker,Protein levels in Keap1-Nrf2 system in human failing heart,"International Journal of Cardiology 225, 62-64",11,2016,6,"M Konishi, A Baumgarten, J Ishida, M Saitoh, SD Anker, J Springer", Stefan D Anker
Stefan D. Anker,Iron therapy in heart failure patients without anaemia: possible implications for chronic kidney disease patients,"Clinical Kidney Journal 10 (suppl_1), i25-i31",11,2017,2,"J Malyszko, SD Anker", Stefan D Anker
Stefan D. Anker,Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF,"Cardiovascular research 118 (8), 1964-1977",11,2022,16,"G Markousis-Mavrogenis, J Tromp, W Ouwerkerk, JP Ferreira, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Heart failure severity and quality of warfarin anticoagulation control (from the WARCEF trial),"The American journal of cardiology 122 (5), 821-827",11,2018,23,"TC Lee, M Qian, GYH Lip, MR Di Tullio, S Graham, DL Mann, K Nakanishi, ...", Stefan D Anker
Stefan D. Anker,Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device‐supported patients for the non‐left …,"ESC heart failure 8 (6), 4409-4424",11,2021,41,"D Milicic, B Ben Avraham, O Chioncel, YD Barac, E Goncalvesova, ...", Stefan Anker
Stefan D. Anker,Sarcopenia in patients after an episode of acute decompensated heart failure: an underdiagnosed problem with serious impact,"Clinical nutrition 40 (6), 4490-4499",11,2021,18,"R Eschalier, G Massoullié, Y Boirie, M Blanquet, A Mulliez, PL Tartière, ...", Stefan Anker
Stefan D. Anker,"Dipeptidyl peptidase 3, a marker of the antagonist pathway of the renin–angiotensin–aldosterone system in patients with heart failure","European Journal of Heart Failure 23 (6), 947-953",11,2021,11,"EM Boorsma, JM Ter Maaten, K Damman, DJ van Veldhuisen, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial,"European Journal of Heart Failure 24 (10), 1883-1891",11,2022,15,"M Böhm, J Butler, F Mahfoud, G Filippatos, JP Ferreira, SJ Pocock, ...", Stefan D Anker
Stefan D. Anker,High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis,"Cardiovascular Research 119 (1), 213-220",11,2023,16,"MC Petrie, PS Jhund, E Connolly, PB Mark, MR MacDonald, M Robertson, ...", Stefan D Anker
Stefan D. Anker,Potential global impact of sodium–glucose cotransporter‐2 inhibitors in heart failure,"European Journal of Heart Failure 25 (7), 999-1009",11,2023,12,"KM Talha, J Butler, SJ Greene, R Aggarwal, SD Anker, BL Claggett, ...", Stefan D Anker
Stefan D. Anker,Has the time arrived to use anticytokine therapy in chronic heart failure,"Dialogues Cardiovasc Med 5, 162-70",12,2000,1,SD Anker,Stefan D Anker
Stefan D. Anker,Impact of finerenone-induced albuminuria reduction on chronic kidney disease outcomes in type 2 diabetes: a mediation analysis,"Annals of internal medicine 176 (12), 1606-1616",11,2023,15,"R Agarwal, W Tu, AE Farjat, YMK Farag, R Toto, S Kaul, R Lawatscheck, ...", Stefan D Anker
Stefan D. Anker,Hand grip strength in patients with advanced cancer: A prospective study,"Journal of Cachexia, Sarcopenia and Muscle 14 (4), 1682-1694",11,2023,23,"S Hadzibegovic, J Porthun, A Lena, P Weinländer, LC Lück, SK Potthoff, ...", Stefan D Anker
Stefan D. Anker,Kommentar zu den ESC-Leitlinien zur Device-Therapie bei Herzinsuffizienz 2010,"Der Kardiologe 6 (1), 5-11",12,2012,3,"CW Israel, SD Anker, G Hasenfuß", Stefan D Anker
Stefan D. Anker,Treatment with iron of patients with heart failure with and without anemia,"Heart Failure Clinics 6 (3), 305-312",12,2010,3,"P Attanasio, SD Katz, SD Anker", Stefan D Anker
Stefan D. Anker,The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea,"Biomarkers 17 (6), 490-497",12,2012,22,"AHB Wu, J Tabas, J Stein, M Potocki, C Mueller, J McCord, M Richards, ...", Stefan D Anker
Stefan D. Anker,Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure–Subanalysis of the WARCEF Trial–,"Circulation Journal 80 (3), 619-626",12,2016,21,"TS Kato, MR Di Tullio, M Qian, M Wu, JLP Thompson, DL Mann, ...", Stefan D Anker
Stefan D. Anker,Enzalutamide in castration-resistant prostate cancer,"N Engl J Med 379 (14), 1380",12,2018,3,"MS Anker, LH Lehmann, SD Anker",Markus S Anker
Stefan D. Anker,Publication trends in cachexia and sarcopenia in elderly heart failure patients,"Wiener klinische Wochenschrift 128 (Suppl 7), 446-454",12,2016,2,"J Springer, SD Anker", Stefan D Anker
Stefan D. Anker,Impact of geographic region on the COMMANDER-HF trial,"Heart Failure 9 (3), 201-211",12,2021,14,"JP Ferreira, JGF Cleland, CSP Lam, DJ van Veldhuisen, WM Byra, ...", Stefan D Anker
Stefan D. Anker,Minimally clinically important difference in health status scores in patients with HFrEF vs HFpEF,"Heart Failure 10 (9), 651-661",12,2022,11,"J Butler, M Shahzeb Khan, JA Lindenfeld, WT Abraham, G Savarese, ...", Stefan D Anker
Stefan D. Anker,Impaired High‐Density Lipoprotein Function in Patients With Heart Failure,"Journal of the American Heart Association 10 (9), e019123",12,2021,13,"JE Emmens, C Jia, LL Ng, DJ van Veldhuisen, K Dickstein, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Differences in biomarkers and molecular pathways according to age for patients with HFrEF,"Cardiovascular research 117 (10), 2228-2236",12,2021,18,"JP Ferreira, W Ouwerkerk, BT Santema, DJ van Veldhuisen, CC Lang, ...", Stefan D Anker
Stefan D. Anker,Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter‐defibrillator for primary prevention?,"European Journal of Heart Failure 24 (9), 1460-1466",12,2022,23,"M Abdelhamid, G Rosano, M Metra, S Adamopoulos, M Böhm, ...", Stefan D Anker
Stefan D. Anker,Population-level implications of sodium-glucose cotransporter-2 inhibitors for heart failure with preserved ejection fraction in the US,"JAMA cardiology 8 (1), 66-73",12,2023,10,"KM Talha, J Butler, SJ Greene, R Aggarwal, SD Anker, BL Claggett, ...", Stefan D Anker
Stefan D. Anker,Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series,"Journal of cachexia, sarcopenia and muscle 14 (5), 1932-1948",12,2023,30,"J McDonald, J Sayers, SD Anker, J Arends, TR Balstad, V Baracos, ...", Stefan D Anker
Stefan D. Anker,The cardiovascular effects of novel weight loss therapies,"European Heart Journal 44 (48), 5036-5048",12,2023,7,"MS Usman, M Davies, ME Hall, S Verma, SD Anker, J Rosenstock, ...", Stefan D Anker
Stefan D. Anker,The association between iron deficiency and outcomes: a secondary analysis of the intravenous iron therapy to treat iron deficiency anaemia in patients undergoing major …,"Anaesthesia 78 (3), 320-329",12,2023,150,"T Richards, LF Miles, B Clevenger, A Keegan, S Abeysiri, R Rao Baikady, ...", SD Anker
Stefan D. Anker,Weight loss in chronic heart failure (CHF) and the impact of treatment with ACE inhibitors-Results from the SOLVD treatment trial,"Circulation 100 (18), 781-781",13,1999,5,"SA Anker, A Negassa, AJS Coats, PA Poole-Wilson, S Yusuf",SA Anker
Stefan D. Anker,"First cachexia symposium, berlin, Germany, 1st–2nd december, 2000","European journal of heart failure 3 (6), 751-754",13,2001,2,"R Sharma, S Anker", Stefan Anker
Stefan D. Anker,2592 Haemoglobin level is associated with adverse outcomes in patients with severe chronic heart failure: results from the COPERNICUS study,"European Heart Journal 5 (24), 487",13,2003,9,"SD Anker, P Mohacsi, AJS Coals, EB Roecker, JL Rouleau, H Krum, ...",SD Anker
Stefan D. Anker,Are diuretics overused in the treatment of chronic heart failure?,"Nature Clinical Practice Cardiovascular Medicine 5 (5), 238-239",13,2008,4,"A Vaz Pérez, SD Anker, R Dietz, M Rauchhaus", Stefan D Anker
Stefan D. Anker,Methods of treating cachexia,"US Patent 7,417,038",13,2008,2,"SD Anker, AJS Coats",Stefan Dietmar Anker
Stefan D. Anker,"Roadmap for cardiovascular education across the European Society of Cardiology: inspiring better knowledge and skills, now and for the future","European heart journal 40 (21), 1728-1738",13,2019,28,"D Kotecha, JJ Bax, C Carrera, B Casadei, B Merkely, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Definition, type, frequency and prognostic impact of anaemia in chronic heart failure","European Journal of Heart Failure Supplements 2, 217-220",13,2003,2,"SD Anker, W Steinborn",Stefan D Anker
Stefan D. Anker,280 body composition and prognosis in 511 chronic heart failure patients: results from three European centers,"European Journal of Heart Failure Supplements 3, 69-69",13,2004,9,"M Cicoira, W Doehner, E Jankowska, L Zanolla, P Zardini, P Ponikowski, ...", SD Anker
Stefan D. Anker,Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour,"Clinical Research in Cardiology 102, 95-101",13,2013,9,"N Ebner, G Földes, T Szabo, M Tacke, S Fülster, A Sandek, W Doehner, ...", Stefan D Anker
Stefan D. Anker,Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations,"European Heart Journal 42 (48), 4887-4890",13,2021,7,"J Butler, SD Anker, G Filippatos, MS Usman, JP Ferreira, F Zannad, ...", Stefan D Anker
Stefan D. Anker,Left ventricular dimensions and cardiovascular outcomes in systolic heart failure: the WARCEF trial,"ESC heart failure 8 (6), 4997-5009",13,2021,10,"K Ito, S Li, S Homma, JLP Thompson, R Buchsbaum, K Matsumoto, ...", Stefan D Anker
Stefan D. Anker,"A population‐based study of 92 clinically recognized risk factors for heart failure: co‐occurrence, prognosis and preventive potential","European journal of heart failure 24 (3), 466-480",13,2022,13,"A Banerjee, L Pasea, SC Chung, K Direk, FW Asselbergs, DE Grobbee, ...", Stefan D Anker
Stefan D. Anker,Nutritional iron deficiency in patients with chronic illnesses,"The Lancet 370 (9603), 1906",13,2007,2,"T Thum, SD Anker", Stefan D Anker
Stefan D. Anker,Identification and management of cancer cachexia in patients: assessment of healthcare providers' knowledge and practice gaps,"Journal of Cachexia, Sarcopenia and Muscle 13 (6), 2683-2696",13,2022,9,"VE Baracos, AJ Coats, SD Anker, L Sherman, T Klompenhouwer, ...", Stefan D Anker
Stefan D. Anker,Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure,"Clinical Research in Cardiology 111 (8), 912-923",13,2022,17,"M Pagnesi, M Adamo, IE Sama, SD Anker, JG Cleland, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Clinical and prognostic relevance of cardiac wasting in patients with advanced cancer,"Journal of the American College of Cardiology 81 (16), 1569-1586",13,2023,29,"A Lena, U Wilkenshoff, S Hadzibegovic, J Porthun, L Rösnick, AK Fröhlich, ...", Stefan D Anker
Stefan D. Anker,Imbalance of catabolic and anabolic pathways in chronic heart failure: Implications for the treatment of cardiac cachexia,"Scandinavian Journal of Nutrition 46 (1), 3-10",14,2002,1,SD Anker,Stefan D Anker
Stefan D. Anker,Loss of the normal coupling between the anaerobic threshold and insulin sensitivity in chronic heart failure,"Heart 82 (3), 348-351",14,1999,5,"F Leyva, TP Chua, IF Godsland, AJS Coats, SD Anker", SD Anker
Stefan D. Anker,Haemoglobin predicts survival in patients with chronic heart failure with a U-shaped curve: a substudy of the ELITE II trial,"EUROPEAN HEART JOURNAL 23, 447-447",14,2002,6,"SD Anker, R Sharma, DF Francis, B Pitt, PA Poole-Wilson, AJS Coats",SD Anker
Stefan D. Anker,The activation of the NF-κB system in chronic heart failure,"Journal of the American College of Cardiology 41 (6S1), 157-157",14,2003,6,"EA Jankowska, A Czarny, E Zaczynska, W Banasiak, SD Anker, ...", Stefan D Anker
Stefan D. Anker,From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature,"European Heart Journal Supplements 4 (suppl_D), D12-D17",14,2002,2,"R Sharma, SD Anker", SD Anker
Stefan D. Anker,Vagal nerve stimulation in chronic heart failure: an antiinflammatory intervention?,"Circulation 110 (4), e34-e34",14,2004,3,"J Springer, DO Okonko, SD Anker", Stefan D Anker
Stefan D. Anker,Pleiotropic effects of angiotensin‐converting enzyme inhibitors and the future of cachexia therapy,"Journal of the American Geriatrics Society 53 (11), 2030-2031",14,2005,3,"S Von Haehling, A Sandek, SD Anker", Stefan D Anker
Stefan D. Anker,Liraglutide for weight loss in obese people,"The Lancet 375 (9714), 551-552",14,2010,2,"T Thum, SD Anker", Stefan D Anker
Stefan D. Anker,Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure?,"The Aging Male 19 (4), 221-230",16,2016,10,"K Kulej-Lyko, J Majda, S von Haehling, W Doehner, M Lopuszanska, ...", Stefan D Anker
Stefan D. Anker,Sleep‐disordered breathing in acute ischemic stroke: a mechanistic link to peripheral endothelial dysfunction,"Journal of the American Heart Association 6 (9), e006010",16,2017,13,"N Scherbakov, A Sandek, N Ebner, M Valentova, AH Nave, ...", Stefan D Anker
Stefan D. Anker,Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta‐analysis,"European journal of heart failure 23 (11), 1960-1970",16,2021,10,"L Lauder, TV Pereira, MC Degenhardt, S Ewen, S Kulenthiran, AJS Coats, ...", Stefan D Anker
Stefan D. Anker,Association between hemoglobin levels and efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency: an AFFIRM-AHF subgroup analysis,"Circulation 147 (22), 1640-1653",16,2023,15,"G Filippatos, P Ponikowski, D Farmakis, SD Anker, J Butler, V Fabien, ...", Stefan D Anker
Stefan D. Anker,Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER‐HF trial,"European Journal of Heart Failure 23 (4), 648-656",16,2021,10,"JP Ferreira, CSP Lam, SD Anker, MR Mehra, DJ van Veldhuisen, ...", Stefan D Anker
Stefan D. Anker,"Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial","European Heart Journal 44 (5), 396-407",16,2023,14,"M Böhm, S Anker, F Mahfoud, L Lauder, G Filippatos, JP Ferreira, ...", Stefan Anker
Stefan D. Anker,Non-invasive assessment of vascular function. Paradoxical vascular response to intravenous glucose in coronary heart disease,"European heart journal 21 (1), 39-44",17,2000,9,"F Leyva, M Rauchhaus, SD Anker, AJ Proudler, IF Godsland, P Stiefel, ...", SD Anker
Stefan D. Anker,Superiority of endothelin-1 over norepinephrine in exercise-induced alterations of the conduit artery tone of the non-exercised arm in patients with chronic heart failure,"International journal of cardiology 73 (1), 15-25",17,2000,9,"M Yousufuddin, W Shamim, JS Chambers, M Henein, FR Amin, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR‐HF trial","European journal of heart failure 25 (6), 902-911",16,2023,30,"D D'Amario, D Meerkin, A Restivo, H Ince, H Sievert, A Wiese, U Schaefer, ...", Stefan D Anker
Stefan D. Anker,"Anticoagulants, antiplatelets, and statins in heart failure","Cardiology clinics 26 (1), 49-58",17,2008,6,"D Farmakis, G Filippatos, M Lainscak, JT Parissis, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency,"European Journal of Heart Failure 24 (5), 821-832",17,2022,16,"J Butler, MS Khan, T Friede, EA Jankowska, V Fabien, UM Goehring, ...", Stefan D Anker
Stefan D. Anker,Relation of longitudinal changes in quality of life assessments to changes in functional capacity in patients with heart failure with and without anemia,"The American journal of cardiology 117 (9), 1482-1487",17,2016,10,"TJ Cooper, SD Anker, J Comin-Colet, G Filippatos, M Lainscak, ...", Stefan D Anker
Stefan D. Anker,Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis,"European Heart Journal-Cardiovascular Pharmacotherapy 9 (2), 183-191",17,2023,18,"G Filippatos, SD Anker, P August, AJS Coats, JL Januzzi, B Mankovsky, ...", Stefan D Anker
Stefan D. Anker,Cardiac expression of neutrophil gelatinase‐associated lipocalin in a model of cancer cachexia‐induced cardiomyopathy,"ESC heart failure 6 (1), 89-97",17,2019,15,"V Musolino, S Palus, C Latouche, M Gliozzi, F Bosco, F Scarano, ...", Stefan D Anker
Stefan D. Anker,Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome,"ESC Heart Failure 7 (5), 2983-2991",17,2020,7,"N Scherbakov, A Barkhudaryan, N Ebner, S von Haehling, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Sodium–glucose co‐transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism,"European Journal of Heart Failure 23, 1250-1255",17,2021,6,"SD Anker, MS Khan, I Shahid, G Filippatos, AJS Coats, J Butler",Stefan D Anker
Stefan D. Anker,Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions,"European Journal of Heart Failure 24 (8), 1400-1405",17,2022,10,"SD Anker, TJ Siddiqi, G Filippatos, F Zannad, JP Ferreira, SJ Pocock, ...",Stefan D Anker
Stefan D. Anker,Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC,"European Journal of Heart Failure 25 (7), 1115-1131",17,2023,43,"M Metra, M Adamo, D Tomasoni, A Mebazaa, A Bayes‐Genis, ...", Stefan D Anker
Stefan D. Anker,Ghrelin. Molecular Metabolism 4 437–460,,18,2015,10,"TD Muller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?,"European Heart Journal 28 (23), 2830-2831",18,2007,3,"S von Haehling, M Lainscak, SD Anker", Stefan D Anker
Stefan D. Anker,& Tschöp,"MH, 437-460",18,2015,6,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker, cardiomyopathy,"International journal of cardiology 112 (1), 114-115",18,2006,2,"YJ Akashi, SD Anker", Stefan D Anker
Stefan D. Anker,Cardiovascular and non‐cardiovascular death distinction: the utility of troponin beyond N‐terminal pro‐B‐type natriuretic peptide. Findings from the BIOSTAT‐CHF study,"European journal of heart failure 22 (1), 81-89",18,2020,12,"JP Ferreira, W Ouwerkerk, J Tromp, L Ng, K Dickstein, S Anker, ...", Stefan Anker
Stefan D. Anker,Guía de práctica clínica de la ESC/ESA 2014 sobre cirugía no cardiaca: Evaluación y manejo cardiovascular: Grupo de Trabajo Conjunto sobre cirugia no cardiaca: Evaluacion y …,Revista española de cardiología 67 (12),18,2014,52,"SD Kristensen, J Knuuti, A Saraste, S Anker, HE Bøtker, S De Hert, I Ford, ...", Stefan Anker
Stefan D. Anker,European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure,"Eur Heart J 33, 1787-1847",18,2012,25,"J McMurray, S Adamapoulos, S Anker, A Auricchio, M Böhm, K Dickstein, ...", S Anker
Stefan D. Anker,Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction,"Scientific reports 12 (1), 8574",18,2022,12,"N Girerd, J Cleland, SD Anker, W Byra, CSP Lam, D Lapolice, MR Mehra, ...", Stefan D Anker
Stefan D. Anker,"Committee American Heart Association Statistics, and Subcommittee Stroke Statistics. 2014.""",Heart disease and stroke statistics--2014 update: a report from the American …,19,,44,"AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...",
Stefan D. Anker,"Antiinflammatory therapy with canakinumab for atherosclerotic disease., 2017, 377","DOI: https://doi. org/10.1056/NEJMoa1707914, 1119-1131",19,,10,"PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ...", SD Anker
Stefan D. Anker,Relation of impaired interorgan communication and parasympathetic activity in chronic heart failure and multiple-organ dysfunction syndrome,"Journal of Critical Care 29 (3), 367-373",19,2014,12,"H Schmidt, U Lotze, A Ghanem, SD Anker, SM Said, R Braun-Dullaeus, ...", SD Anker
Stefan D. Anker,The small intestine: a critical linkage in pathophysiology of cardiac cachexia,"International journal of cardiology 146 (2), 277-278",19,2011,5,"A Sandek, M Valentova, S von Haehling, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study,"International journal of cardiology 161 (3), 137-142",19,2012,10,"W Doehner, J Todorovic, C Kennecke, M Rauchhaus, A Sandek, ...", Stefan D Anker
Stefan D. Anker,Reversibility of cardiac cachexia after heart transplantation,"The Journal of heart and lung transplantation 24 (11), 1757-1762",19,2005,4,"D Habedank, M Hummel, R Hetzer, S Anker", Stefan Anker
Stefan D. Anker,Independent academic Data Monitoring Committees for clinical trials in cardiovascular and cardiometabolic diseases,"European journal of heart failure 19 (4), 449-456",19,2017,27,"GS Filippatos, P de Graeff, JJ Bax, JJ Borg, JGF Cleland, HJ Dargie, ...", Stefan D Anker
Stefan D. Anker,"Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle rapid communications","JCSM Rapid Communications 1 (1), 1-2",19,2018,5,"S von Haehling, N Ebner, JE Morley, AJS Coats, SD Anker", Stefan D Anker
Stefan D. Anker,"Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019",,19,2019,4,"S Haehling, JE Morley, AJS Coats, SD Anker", Stefan D Anker
Stefan D. Anker,MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia,"Journal of Cachexia, Sarcopenia and Muscle 11 (2), 594-605",19,2020,8,"MS Pötsch, J Ishida, S Palus, A Tschirner, S von Haehling, W Doehner, ...", Stefan D Anker
Stefan D. Anker,A clinical tool to predict low serum selenium in patients with worsening heart failure,"Nutrients 12 (9), 2541",19,2020,10,"AA Al-Mubarak, N Grote Beverborg, SD Anker, NJ Samani, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME,"Journal of Hypertension 38 (9), 1829-1840",19,2020,13,"M Böhm, D Fitchett, AP Ofstad, M Brueckmann, S Kaspers, JT George, ...", Stefan D Anker
Stefan D. Anker,Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology,"European Journal of Heart Failure 24 (10), 1767-1777",19,2022,27,"A Bayes‐Genis, A Aimo, P Jhund, M Richards, RA de Boer, H Arfsten, ...", Stefan D Anker
Stefan D. Anker,Empagliflozin in heart failure with predicted preserved versus reduced ejection fraction: data from the EMPA-REG OUTCOME trial,"Journal of Cardiac Failure 27 (8), 888-895",19,2021,15,"G Savarese, A Uijl, LH Lund, SD Anker, FW Asselbergs, D Fitchett, ...", Stefan D Anker
Stefan D. Anker,Assessment of coronary artery disease during hospitalization for cancer treatment,"Clinical Research in Cardiology 110, 200-210",19,2021,17,"SM Mrotzek, A Lena, S Hadzibegovic, R Ludwig, F Al-Rashid, ...", Stefan D Anker
Stefan D. Anker,Safety and efficacy of empagliflozin and diuretic use in patients with heart failure and preserved ejection fraction: a post hoc analysis of the EMPEROR-Preserved trial,"JAMA cardiology 8 (7), 640-649",19,2023,17,"J Butler, MS Usman, G Filippatos, JP Ferreira, M Böhm, M Brueckmann, ...", Stefan Anker
Stefan D. Anker,Cardiac cachexia is a world-wide problem,"International journal of cardiology 71 (2), 113-114",20,1999,2,"R Sharma, SD Anker", SD Anker
Stefan D. Anker,Heart failure therapy: testosterone replacement and its implications,"European heart journal 27 (1), 10-12",20,2006,3,"M Rauchhaus, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,Low plasma triiodothyronine levels in heart failure are associated with a reduced anabolic state and membrane damage,"European journal of endocrinology 164 (6), 937-942",20,2011,9,"G Brenta, J Thierer, M Sutton, A Acosta, N Vainstein, F Brites, L Boero, ...", Stefan Anker
Stefan D. Anker,Management of chronic cardiorenal syndrome,"Cardiorenal Syndromes in Critical Care 165, 129-139",20,2010,5,"P Attanasio, C Ronco, MS Anker, P Ponikowski, SD Anker", Markus S Anker
Stefan D. Anker,Self-rated health predicts adverse events during beta-blocker treatment: The CIBIS-ELD randomised trial analysis,"International journal of cardiology 163 (1), 87-92",20,2013,13,"M Lainscak, J Farkas, S Inkrot, G Gelbrich, AN Neskovic, T Rau, ...", Stefan D Anker
Stefan D. Anker,Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all‐cause mortality,"pharmacoepidemiology and drug safety 24 (7), 738-747",20,2015,10,"IA Gillespie, J Floege, I Gioni, TB Drüeke, AL de Francisco, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Developing models for cachexia and their implications in drug discovery,"Expert opinion on drug discovery 10 (7), 743-752",20,2015,5,"M Konishi, N Ebner, S von Haehling, SD Anker, J Springer", Stefan D Anker
Stefan D. Anker,Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure,"Journal of Cachexia, Sarcopenia and Muscle 6 (4), 325-334",20,2015,13,"P Rozentryt, JT Niedziela, B Hudzik, A Lekston, W Doehner, ...", Stefan D Anker
Stefan D. Anker,The first prognostic model for stroke and death in patients with systolic heart failure,"Journal of cardiology 68 (2), 100-103",20,2016,20,"RS Freudenberger, B Cheng, DL Mann, JLP Thompson, RL Sacco, ...", Stefan D Anker
Stefan D. Anker,New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment,"European journal of heart failure 19 (6), 718-727",20,2017,39,"MR Cowie, GS Filippatos, MLA Alonso Garcia, SD Anker, A Baczynska, ...", Stefan D Anker
Stefan D. Anker,Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology‐Heart Failure Association EURObservational …,"ESC heart failure 7 (5), 2098-2112",20,2020,19,"A Kapłon‐Cieślicka, C Laroche, MG Crespo‐Leiro, AJS Coats, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Effect of ferric carboxymaltose on calculated plasma volume status and clinical congestion: a FAIR‐HF substudy,"ESC Heart Failure 6 (4), 621-628",20,2019,10,"DO Okonko, F Jouhra, H Abu‐Own, G Filippatos, JC Colet, C Suki, C Mori, ...", Stefan D Anker
Stefan D. Anker,Design of a prospective patient‐level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure,"European Journal of Heart Failure 22 (12), 2393-2398",20,2020,11,"M Packer, J Butler, G Filippatos, F Zannad, JP Ferreira, C Zeller, ...", Stefan D Anker
Stefan D. Anker,Pathophysiologic processes and novel biomarkers associated with congestion in heart failure,"Heart Failure 10 (9), 623-632",20,2022,12,"P Pandhi, JM Ter Maaten, SD Anker, LL Ng, M Metra, NJ Samani, ...", Stefan D Anker
Stefan D. Anker,Non‐adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography‐tandem mass spectrometry (results of a …,"European Journal of Heart Failure 23 (7), 1182-1190",20,2021,16,"P Gupta, AA Voors, P Patel, D Lane, SD Anker, JGF Cleland, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Reduced,"European journal of heart failure 24 (10), 1829-1839",20,2022,13,"F Zannad, JP Ferreira, J Gregson, BJ Kraus, M Mattheus, SJ Hauske, ...", Stefan D Anker
Stefan D. Anker,Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced,"European journal of heart failure 24 (12), 2297-2304",20,2022,12,"G Filippatos, SD Anker, J Butler, D Farmakis, JP Ferreira, ND Gollop, ...", Stefan D Anker
Stefan D. Anker,Effect of reduced muscle bulk on the ventilatory response to exercise in chronic congestive heart failure secondary to idiopathic dilated and ischemic cardiomyopathy,"The American journal of cardiology 80 (1), 90-93",21,1997,6,"D Harrington, AL Clark, TP Chua, SD Anker, PA Poole-Wilson, AJS Coats", Stefan D Anker
Stefan D. Anker,Relation of changes over time in ventricular size and function to those in exercise capacity in patients with chronic heart failure,"American Heart Journal 139 (5), 913-917",21,2000,6,"VG Florea, MY Henein, SD Anker, DP Francis, DG Gibson, AJS Coats", Stefan D Anker
Stefan D. Anker,Obesity and survival in chronic heart failure,"Circulation 102 (18), 876-876",21,2000,6,"CH Davos, W Doehner, M Rauchhaus, M Cicoira, DP Francis, SD Anker", SD Anker
Stefan D. Anker,Anaemia of chronic disease in chronic heart failure: the emerging evidence,"European Heart Journal 26 (21), 2213-2214",21,2005,4,"DO Okonko, DJ Van Veldhuisen, PA Poole-Wilson, SD Anker", Stefan D Anker
Stefan D. Anker,Cachexia vs obesity: where is the real unmet clinical need?,"Journal of Cachexia, Sarcopenia and Muscle 4 (4), 245-246",21,2013,2,"S von Haehling, SD Anker", Stefan D Anker
Stefan D. Anker,Reversibility of cachexia after bilateral lung transplantation,"International journal of cardiology 133 (1), 46-50",21,2009,4,"D Habedank, R Ewert, R Hetzer, SD Anker", Stefan D Anker
Stefan D. Anker,Theophylline is able to partially revert cachexia in tumour-bearing rats,"Nutrition & metabolism 9, 1-8",21,2012,13,"M Olivan, J Springer, S Busquets, A Tschirner, M Figueras, M Toledo, ...", Stefan Anker
Stefan D. Anker,Positionspapier zur Detektion von Vorhofflimmern nach ischämischem Schlaganfall,"Aktuelle Neurologie 45 (02), 93-106",21,2018,26,"KG Häusler, K Gröschel, M Köhrmann, RB Schnabel, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Dual antiplatelet or dual antithrombotic therapy for secondary prevention in high-risk patients with stable coronary artery disease?,"Thrombosis and Haemostasis 119 (10), 1583-1589",21,2019,4,"W Sumaya, T Geisler, SD Kristensen, RF Storey",
Stefan D. Anker,Heart failure end points in cardiovascular outcome trials of sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a critical evaluation of …,"Circulation 140 (25), 2108-2118",21,2019,24,"J Butler, M Packer, SJ Greene, M Fiuzat, SD Anker, KJ Anstrom, ...", Stefan D Anker
Stefan D. Anker,Cardiac cachexia: pathophysiology and clinical implications,"BAM-PADOVA- 13 (4), 191-202",24,2003,2,"W Steinborn, SD Anker", SD Anker
Stefan D. Anker,Anemia in chronic heart failure--frequency and prognostic impact.,"Clinical nephrology 60, S103-7",24,2003,3,"W Steinborn, W Doehner, SD Anker", SD Anker
Stefan D. Anker,Statins: a treatment option for chronic heart failure?,"Heart Failure Monitor 4 (3), 90-97",24,2004,3,"S von Haehling, DO Okonko, SD Anker", Stefan D Anker
Stefan D. Anker,The relationship between age and production of tumour necrosis factor-α in healthy volunteers and patients with chronic heart failure,"International journal of cardiology 90 (2-3), 197-204",24,2003,8,"S von Haehling, S Genth-Zotz, R Sharma, AP Bolger, W Doehner, ...", Stefan D Anker
Stefan D. Anker,"Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan","American heart journal 157 (1), 91-96",24,2009,8,"AMS Belonje, BD Westenbrink, AA Voors, S von Haehling, P Ponikowski, ...", Stefan D Anker
Stefan D. Anker,"Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters","International journal of cardiology 156 (1), 62-68",24,2012,7,"R Herrmann, A Sandek, S von Haehling, W Doehner, HB Schmidt, ...", Stefan D Anker
Stefan D. Anker,Current challenges for clinical trials of cardiovascular medical devices,"International journal of cardiology 175 (1), 30-37",24,2014,16,"F Zannad, WG Stough, IL Piña, R Mehran, WT Abraham, SD Anker, ...", Stefan D Anker
Stefan D. Anker,"Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults","The American Journal of Cardiology 114 (6), 909-913",24,2014,16,"NS Bajaj, V Bhatia, K Sanam, S Ather, T Hashim, C Morgan, GC Fonarow, ...", Stefan D Anker
Stefan D. Anker,Steps forward in regulatory pathways for acute and chronic heart failure,"ESC Heart Failure 1 (2), 87-93",24,2014,8,"L Pani, S Pecorelli, G Rosano, SD Anker, A Peracino, L Fregonese, ...", Stefan D Anker
Stefan D. Anker,Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure,"Journal of Molecular and Cellular Cardiology 87, 48-53",24,2015,11,"N Ebner, G Földes, L Schomburg, K Renko, J Springer, EA Jankowska, ...", Stefan D Anker
Stefan D. Anker,"PHARMacy‐based interdisciplinary program for patients with Chronic Heart Failure (PHARM‐CHF): rationale and design of a randomized controlled trial, and results of the pilot study","European Journal of Heart Failure 20 (9), 1350-1359",24,2018,12,"U Laufs, N Griese‐Mammen, K Krueger, A Wachter, SD Anker, F Koehler, ...", Stefan D Anker
Stefan D. Anker,Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study,"Nephrology Dialysis Transplantation 38 (2), 372-383",24,2023,12,"LM Ruilope, B Pitt, SD Anker, P Rossing, CP Kovesdy, R Pecoits-Filho, ...", Stefan D Anker
Stefan D. Anker,Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry,"ESC heart failure 8 (2), 861-871",24,2021,10,"MR Cowie, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ...", Stefan D Anker
Stefan D. Anker,"Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study","European Journal of Heart Failure 23 (1), 145-153",24,2021,11,"MS Anker, S von Haehling, AJS Coats, H Riess, J Eucker, J Porthun, ...",Markus S Anker
Stefan D. Anker,Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference,"Kidney international 104 (4), 655-680",24,2023,64,"E Ku, L Del Vecchio, KU Eckardt, VH Haase, KL Johansen, M Nangaku, ...", Stefan D Anker
Stefan D. Anker,Uric acid as independent predictor of impaired prognosis in patients with chronic heart failure,"Journal of the American College of Cardiology 31, 154-155",25,1998,4,"SD Anker, F Leyva, PA Poole-Wilson, AJS Coats",SD Anker
Stefan D. Anker,Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis,"European journal of heart failure 7 (7), 1105-1111",25,2005,8,"R Wensel, DP Francis, P Georgiadou, A Scott, S Genth‐Zotz, SD Anker, ...", Stefan D Anker
Stefan D. Anker,Obesity and the heart: a weighty issue,"Journal of the American College of Cardiology 47 (11), 2274-2276",25,2006,3,"S von Haehling, W Doehner, SD Anker", Stefan D Anker
Stefan D. Anker,"The cholesterol paradox revisited: heart failure, systemic inflammation, and beyond","Heart Failure Clinics 4 (2), 141-151",25,2008,4,"S von Haehling, JC Schefold, J Springer, SD Anker", Stefan D Anker
Stefan D. Anker,Wytyczne ESC dotycza̧ce rozpoznania oraz leczenia ostrej i przewlekłej niewydolności serca na 2012 rok,"Kardiologia Polska 70 (S2), 101-175",25,2012,27,"JJV McMurray, S Adamopoulos, SD Anker, A Auricchio, M Bohm, ...", Stefan D Anker
Stefan D. Anker,"Рекомендации по диабету, предиабету и сердечно-сосудистым заболеваниям. EASD/ESC","Российский кардиологический журнал, 7-61",25,2014,22,"L Rydén, PJ Grant, SD Anker, C Berne, F Cosentino, N Danchin, ...", Stefan D Anker
Stefan D. Anker,Guidelines ESCCfP,ESC guidelines for the diagnosis and treatment of acute and chronic heart …,25,2012,26,"JJ McMurray, S Adamopoulos, SD Anker, A Auricchio, M Bohm, ...", SD Anker
Stefan D. Anker,Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure—Insight from the Cardiac Insufficiency Bisoprolol Study in Elderly,"International journal of cardiology 161 (3), 160-165",25,2012,13,"I Stankovic, AN Neskovic, B Putnikovic, S Apostolovic, M Lainscak, ...", Stefan D Anker
Stefan D. Anker,"Ghrelin. Molecular Metabolism, 4 (6), 437–460","DOI 10, 1016",25,2015,20,"TD Müller, R Nogueiras, ML Andermann, ZB Andrews, SD Anker, ...", SD Anker
Stefan D. Anker,CHA,"European journal of heart failure 18 (10), 1261-1266",25,2016,22,"S Ye, M Qian, B Zhao, R Buchsbaum, RL Sacco, B Levin, MR Di Tullio, ...", Stefan D Anker
Stefan D. Anker,Myopenia and precision (P4) medicine,"Journal of cachexia, sarcopenia and muscle 8 (6), 857-863",25,2017,2,"JE Morley, SD Anker", Stefan D Anker
Stefan D. Anker,Therapeutic considerations of sarcopenia in heart failure patients,"Expert Review of Cardiovascular Therapy 16 (2), 133-142",25,2018,5,"M Saitoh, N Ebner, S von Haehling, SD Anker, J Springer", Stefan D Anker
Stefan D. Anker,Totality of evidence in trials of sodium–glucose co-transporter-2 inhibitors in the patients with heart failure with reduced ejection fraction: implications for clinical practice,"European Heart Journal 41 (36), 3398-3401",25,2020,5,"J Butler, F Zannad, G Filippatos, SD Anker, M Packer", Stefan D Anker
Stefan D. Anker,Heart failure with preserved ejection fraction according to the HFA‐PEFF score in COVID‐19 patients: clinical correlates and echocardiographic findings,"European journal of heart failure 23 (11), 1891-1902",25,2021,23,"S Hadzibegovic, A Lena, TW Churchill, JE Ho, S Potthoff, C Denecke, ...", Stefan D Anker
Stefan D. Anker,Iron deficiency in CKD without concomitant anemia,"Kidney International Reports 6 (11), 2752-2762",25,2021,6,"JB Wish, SD Anker, J Butler, A Cases, AG Stack, IC Macdougall", Stefan D Anker
Stefan D. Anker,Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology,"European heart journal 43 (9), 863-867",25,2022,30,"AJS Coats, S Heymans, D Farmakis, SD Anker, J Backs, J Bauersachs, ...", Stefan D Anker
Stefan D. Anker,Finerenone and heart failure outcomes by kidney function/albuminuria in chronic kidney disease and diabetes,"Heart Failure 10 (11), 860-870",25,2022,11,"G Filippatos, SD Anker, B Pitt, P Rossing, A Joseph, P Kolkhof, ...", Stefan D Anker
Stefan D. Anker,Role of iron deficiency and anemia in cardio-renal syndromes,"Seminars in Nephrology 32 (1), 57-62",26,2012,5,"P Attanasio, C Ronco, SD Anker, M Cicoira, S von Haehling", Stefan D Anker
Stefan D. Anker,Mobile health applications in cardiovascular research,"International Journal of Cardiology 269, 265-271",26,2018,13,"CMS Sarwar, M Vaduganathan, SD Anker, S Coiro, L Papadimitriou, ...", Stefan D Anker
Stefan D. Anker,Sympatho-vagal imbalance is associated with sarcopenia in male patients with heart failure,"Arquivos brasileiros de cardiologia 112, 739-746",26,2019,10,"GWP Fonseca, MR Santos, FR Souza, MJA Costa, S Haehling, ...", Stefan D Anker
Stefan D. Anker,Decision‐analytic evaluation of the clinical effectiveness and cost‐effectiveness of management programmes in chronic heart failure,"European journal of heart failure 10 (10), 1026-1032",27,2008,9,"A Göhler, A Conrads‐Frank, SS Worrell, BP Geisler, EF Halpern, R Dietz, ...", Stefan D Anker
Stefan D. Anker,"Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference","Journal of cachexia, sarcopenia and muscle 11 (1), 274-285",26,2020,3,"N Ebner, SD Anker, S von Haehling", Stefan D Anker
Stefan D. Anker,A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes,"Kidney international 103 (1), 196-206",26,2023,14,"GL Bakris, LM Ruilope, SD Anker, G Filippatos, B Pitt, P Rossing, L Fried, ...", Stefan D Anker
Stefan D. Anker,Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM‐HF2 trial,"European journal of heart failure 21 (11), 1445-1458",26,2019,10,"M Möckel, K Koehler, SD Anker, J Vollert, V Moeller, M Koehler, S Gehrig, ...", Stefan D Anker
Stefan D. Anker,""" Partnership for the Heart""--development and testing of a new remote patient monitoring system","Deutsche Medizinische Wochenschrift (1946) 132 (9), 458-460",27,2007,10,"F Köhler, M Schieber, S Lücke, P Heinze, S Henke, G Matthesius, T Pferdt, ...", SD Anker
Stefan D. Anker,Is acute heart failure a distinctive disorder? An analysis from BIOSTAT‐CHF,"European Journal of Heart Failure 23 (1), 43-57",26,2021,24,"BA Davison, S Senger, IE Sama, GG Koch, A Mebazaa, K Dickstein, ...", Stefan D Anker
Stefan D. Anker,Big data in cardiovascular disease,"European Heart Journal 38 (24), 1863-1865",27,2017,6,"S Anker, FW Asselbergs, G Brobert, P Vardas, DE Grobbee, M Cronin",Stefan Anker
Stefan D. Anker,The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach,"European journal of heart failure 22 (11), 2102-2111",27,2020,15,"MF Hoes, J Tromp, W Ouwerkerk, N Bomer, SU Oberdorf‐Maass, ...", Stefan D Anker
Stefan D. Anker,Decreased appendicular skeletal muscle mass is associated with poor outcomes after ST-segment elevation myocardial infarction,"Journal of Atherosclerosis and Thrombosis 27 (12), 1278-1287",27,2020,17,"R Sato, E Akiyama, M Konishi, Y Matsuzawa, H Suzuki, C Kawashima, ...", Stefan D Anker
Stefan D. Anker,Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian …,"European Journal of Heart Failure 25 (7), 1080-1090",27,2023,7,"SD Anker, MS Khan, J Butler, S von Haehling, EA Jankowska, ...",Stefan D Anker
Stefan D. Anker,Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study,"European journal of heart failure 24 (1), 192-204",27,2022,15,"RIS Alnuwaysir, N Grote Beverborg, MF Hoes, G Markousis‐Mavrogenis, ...", Stefan D Anker
Stefan D. Anker,Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial,"European Journal of Heart Failure 24 (10), 1928-1939",27,2022,16,"M Metra, EA Jankowska, M Pagnesi, SD Anker, J Butler, F Dorigotti, ...", Stefan D Anker
Stefan D. Anker,Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms,"Cardiovascular Research 118 (10), 2231-2252",27,2022,5,"G Savarese, J Butler, LH Lund, DL Bhatt, SD Anker", Stefan D Anker
Stefan D. Anker,Echocardiographic determinants of mortality in patients> 67 years of age with chronic heart failure,"The American journal of cardiology 86 (2), 158-161",28,2000,9,"VG Florea, MY Henein, M Cicoira, SD Anker, W Doehner, P Ponikowski, ...", Stefan D Anker
Stefan D. Anker,The anti‐CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor‐alpha in patients with chronic heart failure,"European journal of heart failure 8 (4), 366-372",28,2006,8,"S Genth‐Zotz, S von Haehling, AP Bolger, PR Kalra, R Wensel, ...", Stefan D Anker
Stefan D. Anker,Anaemia in chronic heart failure,"Anaemia in chronic heart failure, 79-79",28,2009,2,"SD Anker, SV Haehling",Stefan D Anker
Stefan D. Anker,Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection,"International journal of cardiology 161 (3), 166-173",28,2012,6,"O Hartmann, P Schuetz, WC Albrich, SD Anker, B Mueller, T Schmidt", Stefan D Anker
Stefan D. Anker,"Association of Rheumatologists of Russia, Russian Society for the Study of Pain, Russian Gastroenterology Association, Russian Scientific Medical Society of Therapists …",Rational use of nonsteroidal anti-inflammatory drugs. Clinical guidelines …,28,2018,37,"AE Karateev, EL Nasonov, VT Ivashkin, P Ponikowski, A Voors, S Anker, ...", S Anker
Stefan D. Anker,Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology,"ESC Heart Failure 4 (3), 312-318",28,2017,15,"P Lancellotti, M Galderisi, E Donal, T Edvardsen, BA Popescu, ...", Stefan D Anker
Stefan D. Anker,Primary results of the sensible medical innovations lung fluid status monitor allows reducing readmission rate of heart failure patients (SMILE) trial,"Journal of Cardiac Failure 25 (11), 938",28,2019,19,"WT Abraham, S Anker, D Burkhoff, J Cleland, E Gorodeski, T Jaarsma, ...", Stefan Anker
Stefan D. Anker,Myostatin: regulator of muscle wasting in heart failure and treatment target for cardiac cachexia,"Circulation 121 (3), 354-356",28,2010,3,"J Springer, V Adams, SD Anker", Stefan D Anker
Stefan D. Anker,Remote monitoring of implantable cardioverter-defibrillators and resynchronization devices to improve patient outcomes: dead end or way ahead?,"Ep Europace 21 (6), 846-855",28,2019,4,"F Braunschweig, SD Anker, J Proff, N Varma", Stefan D Anker
Stefan D. Anker,Prevention and reversal of cachexia in patients with chronic heart failure by bisoprolol: results from the CIBIS-II study,"Journal of the American College of Cardiology 41 (6S1), 156-157",29,2003,3,"SD Anker, P Lechat, HJ Dargie",Stefan D Anker
Stefan D. Anker,Excessive ventilation during early phase of exercise: A new predictor of poor long‐term outcome in patients with chronic heart failure,"European Journal of Heart Failure 9 (10), 1024-1031",29,2007,9,"EA Jankowska, T Witkowski, B Ponikowska, K Reczuch, ...", Stefan D Anker
Stefan D. Anker,Obesity paradox as a component of reverse epidemiology in heart failure,"Archives of internal medicine 165 (15), 1797-1797",29,2005,5,"K Kalantar-Zadeh, SD Anker, AJS Coats, TB Horwich, GC Fonarow", Stefan D Anker
